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ABSTRACT 
Background. In the U.S., tuberculosis (TB) continues to disproportionately affect the poor, 
racial/ethnic minorities, and urban dwellers, yet traditional methods of TB control focus 
primarily on biomedical predictors for treatment and less on social factors that could direct 
prevention. Although characteristics of the social and physical environment increase 
vulnerability to TB, declining concern over those with disease and diminished resources have 
stunted understanding of risk and reduced the ability to respond.  
Methods. Using TB case surveillance data combined with genotypic testing of samples from the 
Michigan Department of Health and Human Service and a novel socio-demographic survey, this 
dissertation takes an integrative approach to understanding the patterns of TB incidence and 
transmission.  Research has involved: 1. Analyzing risk factors for TB incidence in Michigan; 2. 
Evaluating which risk factors both at the individual- and neighborhood levels were associated 
with pathogen genotypic and temporal clustering; and 3. Analyzing social characteristics of TB 
cases diagnosed in Metro Detroit to better understand how social vulnerability and behavioral 
contacts augment risk.   
Results. From 2004 through 2012, the incidence of TB throughout Michigan declined by an 
average of 8% per year. However, significant disparities in the average incidence rate were 
observed by race and nativity. Overall, 22% of the foreign-born cases of TB were estimated to be 
resulting from recent transmission of TB compared to 52% of the U.S.-born cases. For the U.S.-
born, recent transmission was predicted more by individual-level and neighborhood-level socio-
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demographic factors than by clinical risk factors.  Preliminary results from the socio-
demographic survey suggest that while individuals with TB in Metro Detroit may be employed 
and have access to stable housing, they still experience significant financial strain. 
Conclusions: The results of this dissertation highlight some of the ways in which TB incidence 
is socially patterned. Interventions aimed at reducing the incidence of TB in the foreign-born 
population should focus on reducing reactivation of latent TB infections.  However, reducing the 
incidence of TB among the U.S.-born will require strategies that can reduce transmission of TB 
among socially disadvantaged groups, both at the individual- and neighborhood-level. In 
addition, continued analysis of the socio-demographic survey will help us further understand the 
social dynamics underlying the persistent disparities observed in TB incidence and transmission. 
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CHAPTER 1. BACKGROUND  
1.1  
1.2 Global Public Health Significance of Tuberculosis 
 “The microbe is nothing…the terrain is everything.” These words spoken by Louis 
Pasteur some time ago remain true today given the current challenges in tuberculosis (TB) 
control—challenges in understanding how and why TB operates differentially among subgroups 
of human populations, challenges in explaining and reducing persistent disparities.  The terrain 
in which TB operates is complex, and therefore successful control of TB will require approaches 
that are multi-faceted encompassing not only the biomedical context of individuals but also the 
social, environmental, and economic context.   
 TB has been around for hundreds of years and yet it still claims over a million lives 
annualy.1 While TB has gone by myriad names: wasting disease, phthisis, and consumption to 
name a few, the etiology and natural history of the disease is unchanged. Given the long-standing 
threat to public health that TB has posed, it is critical that we continue seeking a better 
understanding of the disease and particularly how the disease operates differently within diverse 
populations. Additionally, as drug-resistant TB poses a growing threat to global health, it is even 
more critical to understand the contemporary social and environmental context in which TB lives 
and spreads so as to prevent the spread of drug-resistant TB the future. 
 In 2014, there were an estimated 9.6 million new cases of TB and 1.5 million deaths from 
TB.2 Moreover, TB now parallels HIV as the leading cause of death worldwide; 12% of the new 
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TB cases in 2014 were among HIV-positive persons.2  In addition, multi drug-resistant (MDR) 
TB continues to pose a serious threat to global TB control. It is estimated that if all existing TB 
patients were tested, 300, 000 additional cases of MDR-TB would be detected.3 This is in 
addition to the estimated 480,000 previously diagnosed cases of MDR-TB.3  
 Although TB control measures have successfully reduced TB mortality by 47% since 
1990,2 TB continues to pose special challenges among subgroups of the population—including 
those with HIV, racial/ethnic minorities, immigrant and refugee populations, and other 
vulnerable populations in the global society. While the burden of TB is far less in developed 
countries, the challenge of TB in vulnerable populations remains a salient issue developed 
countries must continue to address.   
1.3  Natural history of Mycobacterium tuberculosis infection 
TB is caused by infection with Mycobacterium tuberculosis (MTB), an acid-fast bacillus 
that is most commonly identified in the lung tissue but can also cause disease in a number of 
non-lung tissues.4 MTB is transmitted via droplets, most often through coughing, singing, or 
sneezing.5 Exposure to MTB results in infection in a limited number of cases; only about 20-30% 
of those exposed to MTB through contact with an active case become infected with the 
bacterium.5  
 There are several factors that determine the probability of transmission of MTB from an 
infectious to a susceptive individual. One, the infectiousness of the individual with TB disease 
determines how many tubercle bacilli are released in the air during a transmission event—a 
greater number of tubercle bacilli released will increase the likelihood of exposure for a 
suceptible.6 Two, environmental factors can affect the concentration of the MTB pathogen in any 
given space/time. These environmental factors include such things as the density of 
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infectious/susceptibles in a space, ventilation, and air pressure.6 Third and finally, the proximity, 
frequency, and duration of exposure also determines the probability of transmission of MTB.6 
The closer in proximity a susceptible is to an infectious case, the higher frequency of exposure, 
and greater duration of exposure time can all increase the likelihood of infection.  
 MTB can enter the body via a number of entry points, the most common being the 
airway.5 Infections via other entry points can produce localized infections at the entry site or 
disseminated infection throughout other organs and tissues via the lymphatic or blood system.5 
Infections that colonize tissue outside of the lungs are considered extra-pulmonary TB (EPTB).5
 Once the MTB pathogen enters the body, TB disease can only arise via one of two 
possible pathways, a process highly regulated by the individual host immune response.5 When 
MTB enters the body it lands on the alveolar surface, activating the initial immune response. The 
alveolar macrophages ingest the microbe triggering the release of cytokines, additional 
macrophages, and T-cells to control the infection.5 This stage of infection is characterized by 
significant growth of the bacterial populations in the body as well as a sustained inflammatory 
response.7 If the inflammatory process continues, individuals develop active TB disease and the 
individual is able to transmit TB to others; this occurs in 5-10% of people infected with MTB.5 
Additionally, it is the induction and the sustained activation of the inflammatory process that 
causes the characteristic tissue damage in the lungs, often resulting in the development of 
cavitary lesions in the lung tissue.7 
 In most cases, however, the body is able to control the initial infection by forming 
granulomas. The granuloma is a tissue nodule created to contain the infection.5,8 The granuloma 
contains the MTB infection and prevents the bacteria from spreading to other sites. Individuals 
whose MTB is contained in granulomas are considered to have latent TB infection (LTBI).8 90-
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95% of individuals who are infected with TB have immune systems that are able to control the 
TB infection, maintaining a state of LTBI.5 However, individuals with LTBI are at risk for 
progression to TB disease. Progression to TB disease occurs when granulomas break open and 
MTB is again able to disseminate throughout the body. Of those individuals with LTBI, 5-10% 
will reactivate and develop TB disease sometime during their lifetime; most within the first 2 
years.5,8 The reactivation of LTBI is extremely context dependent—the most noted risk factors 
for reactivation of LTBI are older age, malnutrition, immunosuppression (especially infection 
with HIV), stress, and other factors affecting cell-mediated immunity.5,8  
 Only those with active TB disease are at risk for transmission of the pathogen to 
susceptible individuals.5 The infectiousness of an active TB case is dependent on the number of 
tuberculosis bacilli that are released in the air in a given exposure event.6 Within active cases, 
several factors have been shown to indicate a high degree of infectivity including: presence of a 
cough, lung cavitation, acid-fast bacilli present on the sputum-smear, TB disease of the lungs, 
airway, or larynx, not receiving adequate drug therapy, and positive sputum cultures.6  
1.4  Diagnosis of MTB Infection and Disease  
 The clinical signs and symptoms of active TB disease are mostly non-specific and could 
apply to a number of disorders. Thus, diagnosis of TB is usually not made solely on the basis of 
clinical symptomology. The clinical manifestations of active TB disease are mainly resultant of 
the replication of a large numbers of TB bacilli in the body in addition to the prolonged 
inflammatory response.5 The most common symptoms are fever, sweats (particularly night 
sweats), and sustained weight loss.5 For pulmonary TB, the addition of a prolonged cough is a 
hallmark syptom.5 The symptoms of EPTB often include fever, sweats, and weight loss as well 
as other symptoms that are specific to the site of disease.  
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 Diagnosis of TB disease differs according to whether the infection is latent or active, 
pulmonary or extra-pulmonary. Primary diagnosis of TB is made through either a tuberculin skin 
test (TST) or a blood test.9 The TST is administered by injecting a small amount of tuberculin 
purified protein derivative under the skin of the forearm.9 Diagnosis of TB through the TST is 
based on the degree of localized immune response and is measured by the millimeters of 
induration at the injection site.9 The TST can be administered and read outside of the laboratory. 
The TB blood test is a laboratory-based test and measures the immune system’s reactivity to the 
bacterium; the blood test used in the U.S. is an interferon-gamma release assay (IGRA).9 A 
positive result for either the TST or an IGRA test only indicates that a person has been 
previously infected with MTB. These tests cannot discriminate between active TB disease or 
LTBI. 
 Further tests are needed in order to discriminate between active TB disease and LTBI. 
Once infection with MTB is diagnosed, a sputum sample is routinely taken. This sputum sample 
is analyzed by microscopy and is used to grow the MTB in culture. The presence of acid-fast 
bacilli in the sputum-smear can confirm active TB disease in the individual.9 The number of 
acid-fast bacilli in the sputum-smear is also counted and used to grade the degree of 
infectiousness of the patient—the greater the number of bacilli, the more infectious the patient.6 
The gold standard of laboratory confirmation of active TB disease is sputum-culture of MTB.6 
Sputum-culture is routinely performed for nearly all suspected active TB cases in the U.S. The 
ability for a sample to grow MTB in culture is also confirmatory of active TB disease.9 Culture 
results are used to both increase the sensitivity of the TB diagnosis as well as provide the 
specimen for drug susceptibility testing and molecular strain typing of isolates.  
 In cases of LTBI, neither the sputum-smear nor the sputum culture will show 
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confirmatory results of TB disease. Thus, while the TST or blood test show the presence of 
infection with MTB, the sputum-smear and sputum culture are needed to confirm whether or not 
the individual is an active case of TB disease.   
 Distinction between pulmonary and EPTB often depends on the clinical signs and 
symptoms the individual displays. For those suspected of pulmonary TB disease, chest 
radiography is often done both to aid the diagnosis of TB as well as survey the extent of tissue 
damage occurring as a result of disease.9 However, chest radiography does not confirm 
pulmonary disease in all patients. For instance, HIV positive persons with active, pulmonary TB 
disease may not show the typical pattern of cavitation or lesions in the lung tissue.6 Thus, chest 
radiography results must be viewed with caution.   
 Symptoms of EPTB are often dependent on the specific tissue or body site in which TB 
disease is occurring. When possible a tissue sample from the suspected site will be taken and 
grown in culture. The tissue culture will be the definitive confirmation of active EPTB.  
1.5 Treatment of LTBI and Active TB  
 TB is a notifiable disease in the United States and the responsibility of successful 
treatment of a TB case falls on the local public health department operating in the area in which 
the case is identified. 10 Private physicians who were involved in the diagnosis of the patient, or 
who serve as primary care providers, may also be involved with the treatment process. However, 
responsibility for completion of appropriate treatment ultimately lies with the local public health 
department. The Centers for Disease Control and Prevention (CDC) has published guidelines for 
treating TB based on the type of disease (pulmonary or EPTB), drug susceptibility, and 
additional patient characteristics.10 Standard treatment for drug-susceptible pulmonary TB starts 
with an 8-week initial phase of therapy consisting of a 4-drug cocktail including: isoniazid, 
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rifampin, pyrazinamide, and ethambutol.10 The continuation phase lasts 18 weeks and consists of 
isoniazid and rifampin.10 Treatment continuation is determined based on monthly sputum 
cultures; 2 consecutive negative sputum cultures would be basis to end treatment after the initial 
6 months.10 In addition, the CDC strongly recommends the use of directly observed therapy 
(DOT) by the local public health agencies as means to enhance adherence to and successful 
completion of drug therapy.10  
 As evidenced above, TB treatment is extensive and often poses many challenges for the 
TB patient to complete a full course of treatment. As such, treatment non-adherence and 
treatment failure are critical issues TB control practitioners must address as they have serious 
implications for the burden of TB in a given area.   
 Treatment non-adherence encompasses any event in which the patient has an inability or 
refuses to take their TB medications as prescribed.6 The reasons for non-adherence can range 
from individual beliefs and behaviors regarding the drug therapy to adverse reactions to 
medications to lack of access to proper health care. The responsibility for ensuring patients finish 
treatment falls all the local health department administering DOT.6   
 Treatment failure is defined as remaining sputum culture-positive while on regular 
treatment for TB.11 The most common reason for treatment failure is non-adherence. However, 
other reasons for treatment failure may include: extensive lung cavitation, drug resistance, issues 
with malabsorption of drugs, and/or laboratory error.10  
 The consequence of both treatment non-adherence and treatment failure is the possibility 
for development of drug-resistant forms of TB. At an individual-level, the development of drug 
resistance leads to poor outcomes for the patient, including persistent TB disease. At a 
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population-level, the new drug-resistant strain of TB can be transmitted to other individuals 
causing drug-resistance to be circulated within a population.  
1.6  Molecular Epidemiology of Tuberculosis  
 The use of molecular biology has become an integral part of epidemiology. The 
application of molecular biology to epidemiology enables the characterization of nucleic acid- or 
amino acid-based strain typing in the service of the goals of epidemiology—that is, the study of 
the distribution and determinants of disease in a given population.12 In infectious disease 
surveillance, the tools of molecular epidemiology can be particularly useful as they allow for 
more sensitive and specific characterization of the pathogen strain and can also aid in identifying 
transmission patterns among cases.12  
 The use of molecular epidemiologic tools has led to enormous advances in TB control 
including increased sensitivity of TB diagnoses, discrimination of TB strain types, and 
identification of genotypic clusters of cases. In addition, previous point of care diagnostic 
services, namely TST and sputum-smear microscopy were subject to a certain degree of 
laboratory and/or clinical error. The use of molecular tools are much less vulnerable to such error 
in the diagnosis of TB, greatly improving the sensitivity of diagnostic services.13 
 MTB has been classified into 6 major lineages, each with multiple classes.14 The strains 
in a given class and lineage differ according to several properties, with some strains being more 
virulent, for example, while others may be resistant to certain drugs.13 The use of molecular 
epidemiologic tools has expanded our ability to analyze the phylogeny of each strain and 
subsequently tailor control strategies based on associated common traits. In addition, the ability 
to differentiate among strains of TB enables us to distinguish whether an individual is infected 
with multiple strains and/or whether the infection is the same strain as previous infections.13    
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 There are three major types of genotyping technology used in TB control, each being 
based on analysis of different components of the MTB genome: restriction fragment length 
polymorphism (RFLP), polymerase chain reaction (PCR)-based spacer oligonucleotide (spoligo) 
yyping, and analysis of mycobacterial interspersed repetitive units (MIRU).5  
 When molecular typing first became prominent in TB research, RFLP techniques were 
primarily used. RFLP in MTB isolates is based on the IS6110 marker and is a simple and 
inexpensive method to distinguish strains of MTB at the subspecies and genotype family levels.13  
RFLP gained prominence in TB research when it was used to identify large clusters of 
genetically similar cases in two outbreak investigations in Los Angeles (1991-1992) and New 
York City (1992).15,16 Since the mutation rate of MTB is low, it is assumed that genotypically 
clustered cases are most likely due to recent transmission of MTB.17 Thus, the excess cases 
occurring in Los Angeles and New York were most likely epidemics of TB transmission 
stemming from only a few index cases.18 This finding challenged the previous held hypothesis 
that TB in the developed world was primarily the result of reactivation of LTBI.13 The outbreaks 
in Los Angeles and New York City were clear evidence that TB transmission was happening in 
the U.S. and elimination would not achieved without greater attention to this issue. 
 RFLP analysis is based on the pattern of IS6110 insertions in the TB genome.19 IS6110 is 
an insertion sequence whose distribution differs depending on the strain.19 Strains stemming 
from a common index case would theoretically have similar patterns of IS6110 distributions.19 
Because the transmission event happened in the past, giving the TB genome time to mutate, 
cases of TB resulting from reactivation of LTBI should have dissimilar IS6110 distributions.19 
Thus, the strength of RFLP method lies in the ability to establish genotypic similarity between 
cases. The weakness of RFLP, however, is that it requires a sample of culture which may take 
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several weeks to obtain.19  
 Spoligotyping, or spacer oligonucleotide typing is based on the distribution of spaces 
between a 36-base pair direct repeat sequence.19 The presence or absence of the spacer differs 
between strains of MTB.19 Spoligotyping technology uses PCR amplification and gel 
electrophoresis to determine the pattern of spacers and compare that to other MTB isolates to 
determine genetic similarity.19 While spoligotyping does not offer equivalent discriminatory 
power compared to RFLP methods, it can be performed using smaller amounts of cultured 
bacterium, allowing for a quicker analysis of specimens.19   
 A more recently developed genotyping method uses mycobacterial interspersed repeat 
units (MIRUs) contained within the MTB genome to examine the number and size of each of 12 
MIRUs.19,20 A variable number of alleles exists at each of the 12 MIRU loci, allowing for many 
possible allelic combinations.19 MIRU-typing is able to discriminate among strains of MTB 
nearly as well as IS6110-based typing, but can be done with less culture using a fully automated 
process that allows for the typing of large quantities of isolates.19 Moreover, further 
discriminatory power can be achieved by including additional loci in the type process.20 
 Although molecular tools may enhance our knowledge and subsequent control of TB, 
there are limitations to the current standards of genotypic investigation.  Reliance upon current 
genotyping methods as the sole basis for establishing transmission is predicated on the 
assumption that two genotypically identical isolates must have arisen from a single source case, 
and represent a transmission event. However, MTB has a low mutation rate, and genotypically 
similar isolates may reflect reactivation events from prior exposure, rather than recent 
transmission.21 For this reason, CDC advocates for the use of a combination of molecular typing 
methods. Improved discrimination between cases can be achieved by combining spoligotyping 
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with MIRU, and/or by expanding the number of MIRU loci analyzed.22 Additionally, the use of 
MIRU is advantageous as it can discriminate between strains nearly as well as RFLP methods 
with less culture time.21,23  
 Despite the enhanced discriminatory power of MIRU, whole genome sequencing 
provides even better resolution in characterizing TB cases.21,24 Whole genome sequencing of 
MTB could provide valuable insights for TB control particularly in terms of differentiation 
between cases resultant from recent transmission from those resultant from reactivation of LTBI. 
Whole genome sequencing can detect microevolution within MTB lineages—changes that were 
previously undetectable.25 By analyzing the pattern of accumulated mutations within isolates, it 
is even possible to infer the direction of transmission.25 Previously TB control has relied on 
epidemiologic data to confirm suspected transmission events. Whole genome sequencing not 
only can highlight transmission events but may also point to individuals who are high 
transmitters. This can be especially helpful in situations where epidemiologic data may be 
difficult to collect.  However, even whole genome sequencing poses challenges. Given the 
novelty of the application of this method to TB control, there is still much work to be done in the 
standardization of the methods by which whole genome sequencing is done.26 Further, while the 
cost of whole genome sequencing has been steadily declining, the low resource setting in which 
many TB control programs operate may prove a barrier to the adoption of routine whole genome 
sequencing. Finally, despite the finer resolution of whole genome sequencing, many researchers 
believe that even whole genome sequencing can be confounded by the low mutation rate of 
MTB.21,26   
 Ultimately, the value of these different molecular methods lies in improved 
characterization of epidemiologic patterns of TB.  In particular, epidemiologic studies of contact 
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patterns and other risk factors should be combined with molecular classification of strains to 
improve the quality and accuracy of inferences regarding transmission links.  
1.7  Epidemiology of Tuberculosis in the United States 
1.7.1 The History of TB in the U.S. 
 In order to understand the current climate of TB in the U.S., it is both helpful and 
necessary to understand the historical context in the U.S. in which TB flourished. In the 1800 
census there were 5.3 million people living in the U.S.27 100 years later the population had 
grown to nearly 76.3 million.27 The population went from 6.1% living in an urban area in 1800 to 
39.6% in 1900.27 Further, from 1820-1967 there were an estimated 44 million new, legal 
immigrants to the U.S.28 TB had been a recurrent health issue in the U.S. prior to this period; 
however, the speed of population growth, the influx of immigrant populations, and the migration 
of populations to cities created conditions under which TB could reach near ubiquity in certain 
populations.  
 Cities, in particular, represented a novel population shift in how people lived and worked. 
And while for many cities symbolized new opportunities for economic growth, they were also 
havens for the spread of infectious diseases. Agrarian populations certainly were exposed to 
infectious diseases before this point. However, the physical space between individuals and 
communities would usually contain the disease before large-scale endemicity could be reached. 
The increasing migration of populations to cities where individuals often lived and worked in 
spaces that were crowded and degraded created the perfect conditions for sustained, large-scale 
outbreaks to occur.  
 New York City was one such focal point of urban migration and accordingly saw one of 
the largest, sustained TB outbreaks document in the U.S. The strategies developed to control TB 
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in New York City are representative of many of the public health approaches of the time. In 1875 
there were 1 million people living in New York City—by 1900 there were 3.5 million people of 
which 1.3 were new immigrants.27 The New York City Health Department was founded in 1870 
to address increasing issues of sanitation and infectious disease in the city.29 At the time, TB was 
the leading cause of death among New Yorkers and would continue to be so for decades.30 
Public health officials instituted robust control measures aimed at both reducing transmission and 
treating active cases. However, even then public health officials recognized the utility of 
improving the social and economic conditions of the population as a way to control the spread of 
TB. As a result of the robust public health measures put in place by the New York City Health 
Department, the city cut the death rate from TB in half between 1910 and 1920.29 
 Despite the ubiquity of TB exposure during the 19th and early-20th centuries, TB 
disproportionately burdened certain subpopulations. And treatments, including admission to the 
increasing numbers of sanatoriums were patterned along lines of social advantage. Sanatorium 
admission was reserved for primarily White, U.S.-born individuals.31 By the early 20th century 
TB control was seeing great successes in reducing both the number of TB cases and deaths 
resultant from TB. Again, however, these successes were concentrated in certain groups. 
Foreign-born persons in the U.S. were still twice as likely to die of TB compared to their U.S.-
born counterparts and African-Americans were nearly three to four times more likely to die of 
TB.31    
1.7.2 Modern-day TB in the U.S. 
 Since 1953, the U.S. government has been routinely collecting surveillance data on TB 
across all states.32 In 1985, the CDC created the Report of Verified Case of TB (RVCT) form, 
the first national tool able to capture patient-level data on demographics, clinical, and laboratory 
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characteristics for each TB case.32,33 The RVCT form is still in use nationally and is augmented 
by the use of MTB genotyping data routinely collected for each case.   
 From 1953-1985, TB incidence rates in the U.S. declined by nearly 82%, corresponding 
to a drop in the annual cases from 53.0 per 100,000 population in 1953 to 9.3 per 100,000 in 
1985.32 However, there was a resurgence of TB from 1986-1992, primarily due to the rising 
HIV/AIDS epidemic and an increase in the number of foreign-born persons in the U.S.32 This 
resurgence of TB resulted in an estimated 52,100 excess cases, with incidence peaking at 10.5 
cases per 100,000 persons in 1992.32 In 1993, U.S. TB incidence began to decline again, and is 
now at its lowest rate since 1953: 3.0 cases per 100,000 population in 2014.32,34 However, in 
recent years the decline has slowed; the average percent decline in TB rates from 1992-2002 was 
6.9% compared to a decline of 4.2% from 2012-2013.32,35  
 While TB has been declining overall within the U.S., TB rates in certain population 
subgroups and geographic areas have not exhibited the same rate of decline. Asian and Pacific 
Islanders (AI/PI) have the highest rates of TB and the incidence rate among this group is not 
showing a decline that will close the gap with other race/ethnicities in the coming years.36 Whites 
have the lowest incidence rate since 1993, a trend that has remained unchanged currently.36 The  
decline in the incidence rate, however, has recently stagnated,32,35 in both urban and rural 
populations37,38 and among foreign-born persons.35 
1.7.3 Social and Environmental Determinants of Tuberculosis  
 The data above are indications of the stark social disparities that still exist in the 
incidence of TB infection and disease in the U.S. Overall, 64.5% of the cases in 2013 occurred in 
foreign-born persons, representing an incidence rate nearly 13 times that of U.S.-born persons.35 
Among the U.S.-born, blacks had an incidence rate 6.2 times that of whites in 2013.35 In the 
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U.S., TB disproportionately affects the poor, racial/ethnic minorities, and those living in urban 
environments.35,39,40 Moreover, TB differentially targets vulnerable populations such as those 
with HIV, the homeless, and the incarcerated.35,39,40  
 Much of the U.S. research concerning the social determinants of TB has been at the 
national level, characterizing trends across states using the National Tuberculosis Surveillance 
System (NTSS). Using the NTSS, Bloss et al. found that incidence among American 
Indian/Alaskan Native populations during 2003-2008 was more than five times greater than that 
of non-Hispanic whites.41 Moreover, case rates for Native Hawaiians/Pacific Islanders were 
more than 13 times that of non-Hispanic whites.41 In a 2011 study characterizing urban TB using 
NTSS data from 2000-2007, Oren et al. found the 48 cities selected for the study accounted for 
36% of the total cases of TB in the U.S., and only 15% of the population of the U.S.37 In 
addition, 29 of the 48 cities under investigation showed no significant change in TB incidence 
rates over the course of the study demonstrating the importance of understanding transmission in 
the urban context.37 Olson et al. also used NTSS data from 1996-2005 to compare the rates of TB 
in U.S.-born populations versus foreign-born populations as well as the distribution of socio-
demographic variables in these two groups.42 They found that for both U.S.-born and foreign-
born populations there was a higher incidence rate of disease in areas of lower socioeconomic 
status (SES).42 This SES gradient was notably steeper for U.S.-born cases than for foreign-born 
cases.42 
 Several studies have begun to investigate TB disease dynamics in more specific contexts, 
namely Washington State, San Francisco, CA, and Baltimore, MD.43–47 A series of studies in 
Washington State have been instrumental in beginning to explicate the pathway between 
neighborhood disadvantage and both TB incidence and disease progression.44–46 In all of these 
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Washington studies, the exposure of interest was a marker of neighborhood-level disadvantage 
based on U.S. census data. The first study found that neighborhood-level disadvantage was 
associated with increased TB incidence even after controlling for individual level age and sex.44 
In the next study, higher neighborhood-level disadvantage was not associated with more severe 
pulmonary TB disease indicating that the neighborhood may be more important for disease 
transmission than disease progression or severity.45 The third study used genotypic clustering as 
a proxy for recent transmission. Genotypic clustering was associated with neighborhood-level 
disadvantage; patients living in areas of higher disadvantage were at higher risk for clustering, 
particularly U.S.-born patients.46  
 There is clear evidence that social factors matter in terms of what puts an individual at 
risk for exposure to MTB as well as what puts an individual at risk for progress to disease once 
infection has occurred. Furthermore, recent studies have suggested that the social environment 
both at the individual- and neighborhood-level plays a critical role in determining risk and 
patterning disparities.   
1.8  Summary & Specific Aims 
 In summary, there is a lack of research aimed at understanding TB incidence patterns in 
terms of both recent transmission and reactivation of latent TB infection in the modern-U.S. 
context, particularly in Michigan. Moreover, while we know there are enduring disparities in the 
incidence of TB in terms of socio-demographic factors, there are few studies that seek to 
understand the drivers of these disparities and the mechanisms by which they continue to persist 
despite organized TB control efforts. The dissertation research proposed below is designed to 
address many of the unanswered questions and troubling patterns described above.  In particular, 
the goal is to improve our understanding of TB by first addressing the TB trends specific to the 
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state of Michigan, a topic for which there is little published literature. Second, we will use 
molecular epidemiology and spatial analysis tools to build upon what is currently known about 
clustering of TB cases by genotype, space, and time within the Michigan TB patients. Finally, 
we will use a subset of the TB population in Metro Detroit to begin to explore in detail the social 
profile of TB patients in hopes to better understand the factors that affect an individual’s 
vulnerability to contracting TB, as well as the factors that affect an individual’s progression to 
TB disease.
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CHAPTER 2. WHY WE SHOULD STILL WORRY ABOUT 
TUBERCULOSIS IN THE U.S.: EVIDENCE OF HEALTH 
DISPARITIES IN TUBERCULOSIS INCIDENCE IN 
MICHIGAN, 2004-2012.  
2.1 Abstract 
Objectives. We examined nine-year trends in tuberculosis (TB) incidence patterns for the entire 
population of Michigan, and within demographic subgroups. 
Methods. Using a cross-sectional study of TB surveillance data, we analyzed 1,254 TB cases 
reported in Michigan during 2004-2012. We used multivariable Poisson regression models to 
study trends in the TB incidence rate for the entire population and by race, nativity, sex, and age.  
Results. Overall, the incidence rate of TB declined by average of 8% per year—10% among 
recently transmitted cases, and 8% among reactivation cases. For recently transmitted disease, 
Blacks had an average incidence rate 19 times greater than Whites, after controlling for nativity, 
sex, and age. For disease resulting from latent TB infection, foreign-born persons had an average 
incidence rate 19 times greater than U.S.-born after controlling for race, sex, and age.  
Conclusions. Disparities in incidence persist despite ongoing TB control efforts. Greater 
disparities were observed by race and nativity demonstrating some of the ways that TB incidence 
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is socially patterned.  Reducing these disparities will require a multi-faceted approach 
encompassing the social and environmental contexts of high-risk populations.  
2.2 Introduction  
 The social underpinnings of tuberculosis (TB) disease have long been documented both 
in historical narratives and scientific literature. Yet, disparities in the incidence of TB related to 
nativity, race, and socio-economic status (SES) continue to persist despite organized TB control 
efforts. Applying a social determinants of health framework to infectious etiologies, specifically 
TB, could shed light on more distal social and environmental factors that may be inhibiting our 
ability to reduce enduring disparities in TB.48 Such an approach may be able to shift our 
understanding from delineation of risk factors to a more comprehensive understanding of the 
processes producing such risk factors.49  
 Despite a resurgence of TB in the U.S. from 1986 to1992, incidence is now at its lowest 
(3.2 per 100,000 in 2012) since routine reporting began in 1953.32,33 That decline, however, has 
recently stagnated,32,35 in both urban and rural populations37,38 and among foreign-born 
persons.35 In addition, incidence of TB in the U.S. is much higher among racial/ethnic minorities, 
people of lower SES, those with HIV, the homeless, and the incarcerated.35,39,40,50,51Consistent 
with various studies that have examined the effects of SES on health,52 TB incidence shows an 
SES gradient, whereby people with lower SES experience greater risk of TB—a gradient much 
steeper among U.S.-born cases.50,53,54  
 Many studies have reported disparities in TB incidence in the U.S., particularly racial 
disparities.55–59 However, few studies have contextualized these disparities in the larger 
framework of social and environmental determinants of health, or offered a thorough 
examination of the mechanisms underlying these disparities. In the late 1980s and early 1990s, a 
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few studies examined the social and geographic context of TB cases as ways to understand the 
increase in TB incidence following the HIV epidemic.54,60,61 More recently, studies in 
Washington State examined the relationship between neighborhood socioeconomic disadvantage 
and TB incidence and disease progression.44–46 Findings suggest that residence in an area with 
greater neighborhood disadvantage is associated with increased TB incidence, accelerated 
progression of disease, and genotypic clustering, particularly among U.S.-born cases. Several 
recent studies posit that SES and/or an unequal burden of TB risk factors may be confounding 
the disparities in TB disease incidence and LTBI between blacks and whites in the U.S.55,56 The 
persistent disparities documented in TB infection and disease raise the question as to if these 
patterns are context dependent. It may be that investigations of the social and geographic context 
of individuals may hold clues for understanding the drivers of TB disparities in different 
contexts, and for designing context-specific interventions to ameliorate them.   
 In the state of Michigan, successes in TB control have resulted in an incidence rate that is 
consistently lower than the national average.36 Yet TB remains a notable public health issue. At 
present, about 75% of TB cases occur in the Detroit Metro Area while only 39% of the Michigan 
population resides there.36,62 Moreover, about half of Michigan TB cases are U.S.-born, 
compared to 37% of the national TB cases.33 In 2010, less than 8 % of the Michigan population 
was foreign-born, compared to 13% of the U.S. population.63 Understanding the differential 
impacts of social factors on TB infection and disease, and specifically how such factors differ for 
recently transmitted versus cases resulting from reactivation of latent TB infection (LTBI), will 
help reduce risk and improve treatment. 
 Using Michigan surveillance data from 2004 to 2012, we examined TB incidence 
patterns for the entire population of Michigan, and within population subgroups. We used both 
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genotypic and temporal data to investigate trends separately for cases due to recent transmission 
and those due to reactivation of LTBI. We specifically sought to document disparities in TB 
incidence by race, nativity, sex, and age in Michigan with the aim of laying the foundation for 
future studies that can explore the mechanisms underlying such disparities.  
2.3 Methods  
2.3.1 Study population and data collection  
 A total of 1,800 TB cases were reported to the Michigan Department of Health and 
Human Services during January 1, 2004 - December 31, 2012 (Figure 2.8-1). The gold standard 
of TB diagnosis is whether TB culture grows from inoculation with a TB sputum and/or tissue 
sample in a laboratory setting. The resulting cultures allow for genotyping of TB isolates giving 
the ability to infer genotypic clusters via two genotypic measures: spoligotyping and 12-locus-
MIRU-VNTR. Therefore, we limited our analyses to only those cases confirmed with a positive 
culture. Of the 1,800 total cases, 1,390 (77%) cases were culture-confirmed; 410 (23%) cases 
were clinical cases that were culture-negative.  The clinical cases were composed of those cases 
that were culture-negative or did not have culture done. The distribution of race, age, sex, 
nativity, geographic area, and site of disease differed significantly comparing the culture 
positive, culture negative, and culture-not done cases (Table 2.8-2).  
 As with previous studies, a genotypic TB cluster was defined as two or more cases with 
identical spoligotype and 12-locus MIRU genotyping patterns in addition to a diagnostic date 
within a one year time period of one another.38,64 Such clusters are not necessarily spatial 
clusters, and could occur over more than one year if the cases were connected by another case 
with an identical genotypic pattern within the one-year time frame.38 If a case did not meet this 
definition, it was classified as a non-clustered case.38 With this time-restricted genotypic cluster 
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definition, clustered cases were considered as a proxy for cases resultant from recent 
transmission; non-clustered cases to be a proxy for cases resultant from reactivation of LTBI. 
The inclusion of a time requirement allows for greater specificity in the classification of a 
genotypic cluster as a case resultant from recent transmission. Therefore, cases were excluded if 
they did not have both a spoligotype and a 12-locus-MIRU-VNTR result. Of the 1,390 culture-
confirmed cases, 1,316 (95%) had both genotypic measures.  
 Demographic and clinical characteristics of the sample were drawn from de-identified TB 
surveillance data collected by the Michigan Department of Health and Human Services using the 
“Report of a Verified Case of TB” form.65 Classifications of race, nativity, sex, and age were 
based on demographic data collected from the above form. We only included participants who 
self-identified as Black, Asian, or White in our racial classification. We focused only on race 
rather than race/ethnicity because the data did not capture multiple ethnic categories. Further, 
only 10% of the sample identified as Hispanic ethnicity. In order to ensure comparability with 
previous studies, age was defined as 18-64 or ≥65years old.38,64 Cases under 18 years of age were 
excluded due to the difficulty in accurately ascertaining pediatric cases.66 Sex and nativity were 
dichotomized as male or female and U.S.-born or foreign-born, respectively. The study sample 
represents 70% of the total number of reported TB cases in Michigan during the study period. 
 The study was approved by the Health Sciences and Behavioral Sciences Institutional 
Review Board at the University of Michigan. 
2.3.2 Statistical Analyses 
 Using a cross-sectional study of TB surveillance data, we analyzed 1,254 TB cases 
reported in Michigan during 2004-2012. Incidence rates for the study time period were 
calculated overall for the study population, clustered and non-clustered cases separately, and then 
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by race, age, sex and nativity.  Geographic variation was not considered because 94% of cases 
were identified in a metropolitan or micropolitan region. To generate the denominators for the 
total population and subgroup incidence rate calculations, population-level characteristics for 
Michigan were obtained from the American Community Survey through the U.S. Census 
Bureau.67 Enumerating the population by nativity, race, sex, and age is considered identifiable 
data according to the U.S. Census. Thus, in order to obtain these subgroup population estimates, 
we took the available population numbers (for example, the number of persons who are foreign-
born, white, and male) and applied the age proportions reported in the American Community 
Survey.  
 We first visually examined the trends in incidence both overall and among subgroups of 
race, nativity, sex, and age.  We plotted the incidence rates over time and calculated the 
confidence intervals based on the Poisson distribution following the method developed by 
Buchanan68 in Microsoft Excel (2011).   
 Poisson regression models were then developed to examine temporal changes in 
incidence overall and among clustered and non-clustered cases, and by subgroups of race, 
nativity, sex, and age. We first modeled the effect of each demographic factor by time (year) 
separately. To determine if the incidence rate trend in clustered cases was statistically different 
from that of non-clustered cases, we used a multinomial logistic regression model comparing the 
average percent decline in clustered and non-clustered cases.69 Multinomial regression models 
allow for the direct comparison between the temporal trends for the two types of cases, a 
limitation of Poisson regression models.  
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 As a final step we used a multivariable Poisson regression with a log link to model the 
average incidence rate ratio by subgroups of the population including all demographic factors. 
 All analyses were conducted in SAS V9.4 and statistical significance was assessed with a 
two-tailed alpha level of 0.05. 
2.4 Results 
 Of the 1,254 cases in the sample, 473 (38%) fit our criteria for a clustered case, while 781 
(62%) were considered non-clustered cases. The 473 clustered cases belonged to 95 unique 
clusters with the size ranging from 2 to 51 cases. 
2.4.1 Characteristics of the study population  
 Of the 1,254 cases analyzed in this study 45% were foreign-born and 55% U.S.-born. The 
sample was 33% White, 42% Black, and 25% Asian. Cases ranged from 18 years of age to 104 
years of age with a median of 49 years of age. 60% of the cases were male, 40% female.  Finally, 
70% of the cases had pulmonary TB, 22% extrapulmonary TB, and 8% had both pulmonary and 
extrapulmonary TB (Table 2.8-1).  
2.4.2 State-wide incidence rate trends  
 From 2004 through 2012, the overall incidence rate of TB declined from 2.69 cases per 
100,000 persons in 2004 to 1.28 cases per 100,0000 in 2012. The average annual percent decline 
was 8%, a statistically significant decline (P < 0.001) (Figure 2.8-2).  
 The incidence rate for both clustered and non-clustered TB declined over the time period. 
The decline in the incidence rate was the largest among clustered TB cases falling from 1.01 per 
100,000 in 2004 to 0.36 per 100,000 in 2012.  This corresponds to a statistically significant 
average annual decline of 10% (P<0.001). The incidence rate of non-clustered TB was 1.68 per 
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100,000 persons in 2004 and 0.92 per 100,000 persons in 2012, corresponding to a statistically 
significant average annual decline of 8% (P<0.001). The observed difference between the 
decline rate of clustered TB and non-clustered TB was statically significant according to the 
multinomial logistic regression model (P < 0.01).  
 Over the nine-year study period, the proportion of cases classified as clustered in the 
study sample decreased while the proportion of non-clustered cases increased. In 2004, clustered 
cases accounted for 38% of the study sample versus 28% in 2012. In 2004, non-clustered cases 
accounted for 62% of all cases versus 72% in 2012.  
2.4.3 Subpopulation incidence rate trends  
 No significant differences were found in the rate of decline in the incidence comparing 
Blacks and Asians to Whites (Figure 2.8-2). Overall, Blacks had an average annual decline in 
the incidence rate of 11%, Asians 7% and Whites 8% (P=0.21 and P=0.67 for Blacks and Asians 
compared to Whites, respectively). Among the clustered cases, Blacks had an average annual 
decline in the incidence rate of 11%, Asians 4% and Whites 11% (P=0.97 and P=0.24 for Blacks 
and Asians compared to Whites, respectively) (Figure 2.8-2). Among non-clustered cases, 
Blacks had an average annual decline in the incidence rate of 11%, Asians 7%, and Whites 7% 
(P=0.20, P=0.86 for Blacks and Asians compared to Whites, respectively) (Figure 2.8-2).  
 There was a significant difference in the decline rate overall by nativity. However, this 
difference was attenuated when clustered and non-clustered cases were examined separately 
(Figure 2.8-2). Overall, the U.S.-born had an average annual decline of 8% and foreign-born 6% 
(U.S.-born vs. foreign-born: P=0.03).  Among clustered cases, the U.S.-born had an average 
annual decline in the incidence rate of 11% and foreign-born 4% (U.S.-born vs. foreign-born: 
P=0.06). Among non-clustered cases, the U.S.-born had an average annual decline in the 
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incidence rate of 10% and foreign-born 7% (U.S.-born vs. foreign-born: P=0.25).   
 There were no differences in the rate of decline in the incidence by sex (Figure 2.8-2). 
Overall, males had an average annual decline in the incidence rate of 7% and females 10% (male 
vs. female: P=0.17). Among clustered cases, males had average annual decline of 9% and 
females 11% (male vs. female: P=0.68). For non-clustered cases, males had an average annual 
decline in the incidence rate of 6% and females 10% (male vs. female: P=0.13).  Likewise, the 
two age groups did not differ in the rate of decline in the incidence (Figure 2.8-2). Overall, the 
18-64 year age group had an average annual decline in the incidence rate of 9% and the 65+ age 
group 7% (65+ vs. 18-64: P=0.29). Among clustered cases, the 18-64 year age group had an 
average annual decline in the incidence rate of 9% per year and the 65+ age group 12% (65+ vs. 
18-64: P=0.57). This trend was reversed among the non-clustered cases, the 18-64 age group had 
an average annual decline in the incidence rate of 9% compared to the 65+age group of 5% (65+ 
vs. 18-64: P=0.16).  
2.4.4 Comparison of average incidence rate among subpopulations  
 We next evaluated whether there were significant differences in the average incidence 
rate ratio across subgroups for both clustered and non-clustered TB cases. Given no significant 
differences in the decline rate were found among subgroups when the demographic factors were 
examined one at a time, interactions between time and demographic factors were not included in 
the multivariable analysis. The greatest disparities in the average incidence rate, for both 
clustered and non-clustered cases, were observed by race and nativity (Table 2.8-2). However, 
the magnitude of the disparity differed between clustered and non-clustered cases. 
 Among clustered TB cases, Blacks had an average incidence rate 19 times greater than 
Whites, with Asians at nearly 8 times greater incidence than Whites, after controlling for 
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nativity, sex, and age (Table 2.8-2).In the same model, the foreign-born had an average 
incidence rate 5 times greater than the U.S.-born after controlling for race, sex, and age (Table 
2.8-2). 
 Disparities were also observed in the non-clustered model, particularly by nativity. In the 
non-clustered model, the foreign-born had an average incidence rate 19 times greater than that of 
the U.S.-born when controlling for race, sex, and age  (Table 2.8-2). Racial disparities were also 
observed: Blacks had an average incidence rate 6.5 times greater than that of Whites, Asians 4 
times greater than that of Whites, when controlling for nativity, sex, and age (Table 2.8-2). 
2.5 Discussion  
 This study analyzed temporal changes in TB incidence patterns in Michigan during 2004-
2012, with particular attention to subgroups by race, nativity, sex, and age. We found the 
incidence rate of TB to be declining overall in Michigan. This decline was similar for recently 
transmitted cases and reactivated cases. Our results suggest both ongoing transmission and 
reactivation of LTBI are contributing to the burden of TB disease in Michigan. There were 
significant subgroup disparities in the average incidence rate, particularly by race and nativity.  
 On the whole, TB incidence is declining in the U.S. We observed an average yearly 
percentage decline of 8% in the incidence, greater than the average percentage decline (5%) 
reported for the U.S. as a whole in this time period.33,70–77 The greater decline in Michigan might 
be partly explained by a population composition that differs from many of the more populous 
states contributing to the national TB burden such as California, Texas, New York, and Florida 
who accounted for nearly half of all TB cases in 2014.34 The higher TB incidence rate in these 
states may be driven by their proximity to countries with an elevated TB burden, as well as a 
larger proportion of foreign-born persons as compared with Michigan.78  
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 Our findings showed that both ongoing transmission and reactivation of LTBI are 
contributing to TB incidence in Michigan. Shea et al. reported 80% of U.S. TB cases during 
2006-2008 resulted from reactivation of LTBI.79 Similarly, the highest proportion of Michigan 
cases also resulted from reactivation of LTBI. Studies in Arkansas have reported similar 
findings, though with smaller proportions of cases attributable to reactivation.38,64 Based on our 
analysis, TB control efforts need to implement measures that can both reduce Mycobacterium 
tuberculosis transmission and reduce reactivation of LTBI.  
 In general, we did not find significant differences in the TB decline rate in our subgroup 
analyses. However, there was evidence of disparities in the average incidence rate. Among 
recently transmitted cases, the greatest disparities were observed by race with Blacks being the 
highest risk group. The evidence is mixed regarding the racial distribution of TB.  While some 
studies have also reported the greatest racial disparity in TB incidence between Blacks and 
Whites,80 the national surveillance data suggests the greatest racial disparities exist between 
Asians and Whites.34 Our multivariable models allowed us to explore these disparities while 
accounting for the effects of nativity. We saw the disparity between Asians and Whites reduced 
by nearly 40% when accounting for nativity. Conversely, the disparity between Blacks and 
Whites increased when we accounted for nativity. These findings suggest that nativity is 
suppressing the relationship between race and TB. Thus, accounting for nativity is critical to 
understanding the relationship between race and TB incidence.  
 Among cases resulting from reactivation of LTBI, the greatest disparities were observed 
by nativity. Immigrants may be infected in their country of origin and may reactivate sometime 
later when in the U.S. 81–83 However, the disparity observed between foreign-born and U.S.-born 
persons among the recently transmitted cases suggests they are also at risk for acquiring TB 
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infection while in the U.S. This may be resultant from increased exposure to active TB cases 
among other recent immigrants or it could it be a reflection of their social and environmental 
circumstances once in the U.S.  
 Our study is one of only a few to use a multivariable approach to disentangle the 
differential impact of socio-demographic factors on disparities in TB incidence in the U.S. 
Bivariate analyses of the socio-demographic patterning of TB risk miss important relationships 
that are only uncovered when controlling for other factors. Other studies that have used a 
multivariable approach have also found that social vulnerability based on minority race/ethnicity, 
nativity, and income was a better predictor of TB incidence than traditional TB risk factors.84 
 During the 19th and early 20th centuries TB was thought to be endemic in the U.S., 
particularly among those living in poor, crowded housing without access to basic resources: 
clean water, sanitation, ample food.85,86 Yet, in recent decades the focus in infectious disease 
control in the U.S. has shifted to individual-level predictors of risk and disease, often ignoring 
the social and environmental context of individuals that may be more a salient predictor of risk. 
Our findings that disparities are not only present in TB incidence, but persistent despite 
organized TB control efforts, suggest that TB controls needs to begin again to address the social 
and environmental context in which TB cases are arising. It is not sufficient to simply describe 
the patterns of TB incidence without regard to how these factors are working together to 
augment risk in certain populations.  
 Additionally, despite our knowledge of the highly social nature of TB, control efforts in 
the U.S. rarely emphasize the social and environmental context as means for intervention. 
Recently, the World Health Organization has begun to recognize the inextricable links between 
social and economic determinants of TB incidence globally.85,87 Globally, the burden of TB often 
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disproportionately falls on the most vulnerable populations. Hargreaves et al. suggests that global 
TB control needs to develop interventions that simultaneously incorporate the traditional 
biomedical approaches as well as approaches that address the social determinants of health.87 
These efforts have mainly been targeted to high-burden TB countries in order to reduce the 
global incidence of TB. However, we advocate for an extension of this expansive view of TB 
control to low burden TB settings as TB disparities often remain persistent in these settings.  
While many studies show social factors ranging from neighborhoods to social cohesion to be 
meaningful predictors of TB risk, we now need to move to incorporating these findings into TB 
control in the U.S.  
2.6 Limitations 
 There were several limitations to our study regarding the exclusion criteria we applied to 
the selection of the study sample. Since our analyses were contingent upon the availability of 
genotypic data, we excluded 410 clinical cases (23% of the 1,800 cases reported in Michigan 
during this time). These cases were significantly different than culture-positive cases on a 
number of key covariates (Table 2.8-2).  However, we believe the final study sample is 
representative of the total TB population and therefore, our findings are not significantly biased 
due to this exclusion (Table 2.8-1). Additionally, we excluded those cases less than 18 years of 
age (6.88% of the total 1,800 cases reported in Michigan during this time).  Several studies have 
posited that pediatric cases are more likely to be recently transmitted TB thus excluding them 
could lead to an underestimation of the true trends in recent transmission.88  
 One critical limitation to our study was the availability of more detailed socio-
demographic data. While our findings suggest significant social patterning of TB incidence, our 
ability to infer what may be driving the observed disparities is limited based on the data 
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available. Future studies would benefit from the collection of more detailed socio-demographic 
data.  Additionally, our incidence rate calculations were based on extrapolations of census data. 
Updated population denominators were not available for all years, possibly reducing accuracy of 
some population-level data. However, the resulting bias is likely non-differential, biasing the 
observed estimates towards the null.  
  We used genotypic clustering as a proxy for recent transmission. While we believe that 
the addition of a time restriction in our genotypic cluster definition increased the specificity of 
the designation, some misclassification may still have occurred, particularly for those cases 
diagnosed in 2004. To be classified as clustered, a case had to share a genotype and a diagnostic 
date within one year of another case. Thus, there may have been some 2004 cases that were 
misclassified as non-clustered since we could not link them to cases diagnosed in 2003 because 
of non-comparable genotyping data for the 2003 cases. However, we do not believe this 
substantially biased our findings.  Additionally, some studies have shown that the use 
spoligotyping and 12-locus-MIRU-VNTR as a marker as the basis for genotypic clustering may 
not be as effective depending on the strain of Mycobacterium tuberculosis.89 Thus, future 
analyses should consider the prevalent MTB strain when deciding on the classification scheme 
for genotypic clusters.  
2.7 Conclusions  
 This is the first study offering a more in-depth analysis of the trends in TB incidence in 
Michigan. Our findings suggest that both ongoing transmission and reactivation of LTBI are 
contributing to the incidence of TB in Michigan. Disparities in incidence persist despite ongoing 
TB control efforts, suggesting more targeted TB control is needed to reduce incidence in high-
risk groups. The greater disparities by race and nativity demonstrate some of the ways that TB 
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incidence is socially patterned.  Reducing these disparities will require a multi-faceted approach 
encompassing the social and environmental contexts of high-risk populations.
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2.8 Tables & Figures  
Table 2.8-1 Comparison of the Distribution of Selected Demographic and Clinical 
Characteristics Among all Culture-Confirmed Cases and the Study Sample.   
 All culture-
confirmed cases 
(n=1,390) 
Study Sample 
(n= 1,254) 
Risk Factor No. % No. % 
Race     
White 460 33.09 419 33.41 
Black/African 
American 
577 41.51 525 41.87 
Asian 328 23.60 310 24.72 
American 
Indian/Alaskan Native 
5 0.36   
Native Hawaiian or 
Other 
10 0.72   
Unknown 10 0.72   
Missing     
Age      
<18 40 2.87   
18-64 1004 72.24 939 74.88 
65+ 346 24.89 315 25.12 
Sex      
Male 842 60.62 750 59.81 
Female 547 39.38 504 40.19 
Missing 1    
Nativity       
Foreign-born 609 43.91 557 44.52 
US-born 778 55.09 694 55.48 
Missing 3  3  
Geographic Area      
Metro 1300 93.53 1176 93.78 
Micro 42 3.02 39 3.11 
Rural 6 0.43 5 0.40 
Unknown 42 3.02 34 2.71 
Missing     
Site of Disease     
Pulmonary 972 70.03 880 70.29 
Extrapulmonary 303 21.83 275 21.96 
Both 113 8.14 97 7.75 
Missing 2  2  
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Table 2.8-2 Comparison of the Distribution of Selected Covariates Among all Reported TB 
Cases, Culture Positive, Culture Negative, and Culture-Not Done Cases.  
 
All reported 
TB cases 
(n=1,800) 
Culture Pos  
(n=1,390) 
Culture Neg  
(n=259) 
Culture-ND 
(n=151) 
 
No. % No. % No. % No. % 
Race                 
White 618 34.39 460 33.09 107 41.31 51 33.77 
Black/African American 721 40.12 577 41.51 79 30.5 65 43.05 
Asian 428 23.82 328 23.6 71 27.41 29 19.21 
American Indian/Alaskan 
Native 
5 0.28 
5 0.36 0 0 0 0 
Native Hawaiian 3 0.17 2 0.14 0 0 1 0.66 
Other 11 0.61 8 0.58 2 0.77 1 0.66 
Unknown 11 0.61 10 0.72 0 0 1 0.66 
Missing 3 0.17 0 0 0 0 3 1.99 
Age (years)      
      <18 124 6.88 40 2.88 24 9.27 60 39.74 
18-64 1263 70.16 1004 72.23 184 71.04 75 49.67 
65+ 413 22.94 346 24.89 51 19.69 16 10.6 
Sex      
      Male 1047 58.2 842 60.58 143 55.21 62 41.06 
Female 752 41.8 547 39.35 116 44.79 89 58.94 
Missing 1   1 0.07 0 0 0 0 
Nativity       
      Foreign-born 798 44.48 609 43.81 132 50.97 57 37.75 
US-born 996 55.52 778 55.97 127 49.03 91 60.26 
Missing 6   3 0.22 0 0 3 1.99 
Geographic area      
      Metro 1690 94.05 1300 93.53 247 95.37 143 94.7 
Micro 49 2.73 42 3.02 5 1.93 2 1.32 
Rural 9 0.5 6 0.43 2 0.77 1 0.66 
Unknown 49 2.73 42 3.02 5 1.93 2 1.32 
Missing 3 0.17 0 0 0 0 3 1.99 
Site of Disease     
      Pulmonary 1188 66.22 972 69.93 145 55.98 71 47.02 
Extrapulmonary 463 25.81 303 21.8 91 35.14 69 45.7 
Both 143 7.97 113 8.13 22 8.49 8 5.3 
Missing 6   2 0.14 1 0.39 3 1.99 
Culture-Pos = Culture status positive; Culture-Neg = Culture status negative; Culture-ND = Culture 
not done which includes those with an unknown culture status.  
*Chi square tests were permed comparing the distribution of each covariate between culture-positive, 
culture-negative, and culture-not done TB cases. The distribution of each covariate was statistically 
different comparing each TB case type (P < 0.001).  
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Table 2.8-3. Incidence Rate Ratio of TB According to Selected Socio-Demographic 
Characteristics in Michigan, 2004-2012. 
 
Clustered Cases Non-Clustered Cases 
Variable IRR (95% CI) IRR (95% CI) 
Race 
  
White Ref. Ref. 
Black 19.01 (17.64, 20.48) 6.54 (6.17, 6.93) 
Asian 7.79 (6.89, 8.79) 4.00 (3.75, 4.27) 
   Origin 
  
U.S.-born Ref. Ref. 
Foreign-born 4.91 (4.45, 5.40) 19.19 (18.12, 20.33) 
   Sex 
  
Male Ref. Ref. 
Female 0.49 (0.46, 0.52) 0.74 (0.71, 0.78) 
   
Age 
  
18-64 Years Ref. Ref. 
65+ Years 1.01 (0.93,1.11) 3.05 (2.90, 3.20) 
   
Models based on multivariate Poisson regression  
IRR = incidence rate ratio  
 Ref. = reference group  
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Culture-confirmed cases: 1,390 (77% of 
reported cases) 
All cases with a positive culture result (either 
sputum or other tissue) 
Figure 2.8-1 Flowchart Illustrating the Selection of the Study Sample from the 1,800 Total TB 
Cases Reported in Michigan, 2004 - 2012.  
 
 
 
 
 
 
 
 
 
All TB cases reported in Database: 1,800  
All cases diagnosed from 01/01/2004 – 12/31/2012  
Excluded due to being clinical 
cases: 410 (23% of reported 
cases) 
All cases diagnosed only by 
clinical characteristics 
Cases with Genotyping Data: 1316 (95% of 
culture-confirmed cases) 
All cases with both spoligotype and 12-locus-
MIRU-VNTR 
Excluded due to lack of 
genotyping data: 74 cases (5% of 
culture-confirmed cases) 
genotypic data were removed. 
 
 
Final Cases Analyzed: 1,254 
(90% of culture-confirmed 
cases) 
Those cases identified as White, 
Black, or Asian and ≥ 18 years of 
age. 
Excluded cases based due to a) race 
other than White, Black, or Asian, or 
b) < 18 years of age: 62 cases (10 % 
of culture-confirmed cases) were 
removed. 
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Figure 2.8-2 The Incidence Rate of Clustered and Non-Clustered TB Cases by Race, Nativity, Sex, and Age in Michigan, 2004-2012. 
For all figures, the error bars correspond to the 95% confidence interval. 
Figure 1-2 a. Compasisons by race   
 
 
 
 
 
 
 
 
Figure 1-2 b. Comparisons by nativity 
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Figure 1-2 c. Comparisons by sex  
Figure 1-2 d. Comparisons by age 
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2.8-4 Supplemental Table. Comparison of the distribution of selected demographic and clinical 
characteristics among all reported cases in Michigan and the study sample.   
 All reported TB 
cases (n=1,800) 
Study Sample 
(n= 1,254) 
Risk Factor  No. % No. % 
Race     
White  618 34.39 419 33.41 
Black/African American  721 40.12 525 41.87 
Asian  428 23.82 310 24.72 
American Indian/Alaskan 
Native  
5 0.28   
Native Hawaiian or Other  3 0.17   
Unknown 22 1.22   
Missing  3    
Age groups (years)      
<18  124 6.88   
18-64 1263 70.16 939 74.88 
65+ 413 22.94 315 25.12 
Sex      
Male  1047 58.20 750 59.81 
Female  752 41.80 504 40.19 
Missing  1    
Place of birth      
Foreign-born 798 44.48 557 44.52 
US-born 996 55.52 694 55.48 
Missing  6  3  
Geographic area      
Metro 1690 94.05 1176 93.78 
Micro  49 2.73 39 3.11 
Rural  9 0.50 5 0.40 
Unknown 49 2.73 34 2.71 
Missing      
Site of disease     
Pulmonary  1188 66.22 880 70.29 
Extrapulmonary  463 25.81 275 21.96 
Both  143 7.97 97 7.75 
Missing  6  2  
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CHAPTER 3. DRIVERS OF MYCOBACTERIUM 
TUBERCULOSIS TRANSMISSION IN THE U.S. 
CONTEXT 
3.1 Abstract 
Objectives: Using TB surveillance data and molecular genetic tests of Mycobacterium 
tuberculosis, we evaluated risk factors for TB clustering at both the individual and neighborhood 
levels among U.S.-born and foreign-born populations. We used genotypic clustering as a proxy 
for recent transmission.  
Methods: Using TB surveillance data, we analyzed 1,236 TB cases reported in Michigan during 
2004-2012. We used univariate and multivariable, modified Poisson regression models to 
examine risk factors for TB genotypic clustering cross-sectionally for U.S.-born and foreign-
born populations separately. Genotypic clusters were defined on the basis of spoligotype and 12-
locus-MIRU-VNTR typing results. We examined four classes of variables: demographic factors, 
known TB risk factors, clinical factors, and neighborhood-level factors.   
Results: Overall, 22% of the foreign-born cases of TB were clustered. Among the foreign-born, 
only race and being a contact of a known case of active TB were significant predictors of 
clustering. 52% of the U.S.-born cases of TB were clustered. For the U.S.-born, clustering was 
predicted more by individual-level and neighborhood-level socio-demographic factors than by 
clinical risk factors.  
  
 41 
Conclusions: Interventions aimed at reducing the incidence of TB in the foreign-born population 
should focus on reducing reactivation of LTBI.  However, reducing the incidence of TB among 
the U.S.-born will require strategies that can reduce transmission of TB among socially 
disadvantaged groups, both at the individual- and neighborhood-level.  
3.2 Introduction  
 Although the overall incidence of tuberculosis (TB) has been declining in the U.S., stark 
disparities persist in the distribution of disease, particularly by race and nativity.  Asian and 
Pacific Islanders (AI/PI) continue to have the highest rates of TB with no evidence of closing the 
gap with Whites.36,41 Moreover, in recent years the rate of decline in TB incidence has begun to 
stagnate particularly among foreign-born populations,35 and in both urban and rural 
populations.37,38 A study using cases from the National Health and Nutrition Examination Survey 
(NHANES), 1999-2000, also found evidence of disparities in latent TB infection (LTBI) among 
African Americans and Hispanics born in the U.S., the foreign-born, and those in poverty.90 
 Previous studies have examined both individual-level and neighborhood-level factors 
linked to transmission. Individual-level risk factors for recent transmission include demographic 
characteristics such as younger age,91–93minority race/ethnicity status,91,94 male sex,92,93 and 
being native-born.47,91,94,95 Additionally, several of the traditionally recognized TB risk factors 
published by the Center for Disease Control and Prevention (CDC) 65 such as 
homelessness,47,91,92 incarceration,91 and drug use47 have also been linked with increased risk of 
recent TB transmission. Further, neighborhood-level studies have indicated that area-based 
measures of disadvantage are associate with increased rates of TB transmission, a finding 
particularly pronounced for U.S.-born populations.46  
 Rodwell et al. found that while many of the aforementioned risk factors appeared to be 
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statistically significant in univariate analyses, few retained their significance in multivariable 
models.92 Moreover, the most significant factors in multivariable factors were not clinical, but 
rather indicators of social disadvantage. However, there are few studies that use multivariable 
models to investigate risk factors for TB transmission. Furthermore, several investigations have 
suggested the risk factors for transmission are different for foreign-born and U.S.-born 
populations.96  Studies that do not separate these two populations may produce incorrect 
inferences regarding the drivers of transmission. This reinforces the need for research that 
accounts for population-specific risk factors for TB transmission using multivariable techniques 
that can disentangle the independent risk associations.   
 In 2012, Michigan had an annual incidence rate of 1.28 TB cases per 100,00097—notably 
lower than the national incidence rate of 3.2 per 100,000.35 Despite being a low-incidence state, 
there is evidence of persistent disparities in TB incidence, particularly by race and nativity. In 
studies examining only recently transmitted cases, Blacks had an incidence rate nearly 19 times 
greater than Whites.97 This is in contrast to  the incidence of reactivation of LTBI in foreign-born 
people that is 19 times greater than the U.S-born.97 These studies not only suggest that the 
drivers of transmission may differ from those of the reactivation of LTBI, but also these 
relationships may be fundamentally different between U.S.-born and  foreign-born populations. 
Using TB surveillance data collected by the Michigan Department of Health and Human 
Services, we evaluated risk factors for TB transmission at both the individual- and 
neighborhood-level among U.S.-born and foreign-born populations separately. Despite Michigan 
having a relatively low number of TB cases, transmission is still occurring, and perhaps 
disproportionately more so among the most vulnerable.  
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3.3 Methods  
3.3.1 Study population and data collection  
 A total of 1,800 cases of TB were reported in Michigan from January 1, 2004 to 
December 31, 2012.  Of those, 1,390 (77%) were culture-confirmed and 410 (23%) were culture-
negative clinical cases.  Of the 1,390 culture-confirmed cases, 1,316 (95%) had complete 
genotype data available, including spoligotype and 12-locus-MIRU-VNTR results.  
 Our study sample was drawn from the 1,316 cases with complete genotype data and 
address information. Cases were excluded if they did not have both spoligotype and 12-locus-
MIRU-VNTR results. Cases were also excluded if they did not have complete address 
information. The final study sample consisted of 1,236 cases, representing 69% of the 1,800 total 
cases reported during this time period.  
 Demographic and clinical characteristics of cases were drawn from TB surveillance data 
collected by MDHHS using the “Report of a Verified Case of TB” (RVCT) form developed by 
the Centers for Disease Control and Prevention (CDC).65 Additionally, we included variables 
defined on the RVCT form as “known TB risk factors.” Individuals were linked to their 
particular census block group by the address reported on the RVCT form. Such addresses were 
geocoded and subsequently linked with block group-level census data. Additionally, 104 cases 
(6% of the total 1,800 cases reported in Michigan) were missing address information and were 
therefore excluded from the analysis (Table 3.8-6). The 104 cases missing address information 
included those missing addresses altogether, those coded as homeless, and those with addresses 
listed as a hospital or laboratory. These cases were significantly different than those with address 
information by race, nativity, geographic area, and site of disease. 
 Block group characteristics were derived from the American Community Survey (ACS), 
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5-year estimates for 2012.98 We used the block group as the unit of analysis for neighborhood 
effects because we believe that features of the block group can be a proxy for  both household-
level features such as degraded housing and vacancy and as well as access to neighborhood 
resources. We believe both dimensions could affect TB transmission. We defined block group-
level disadvantage by developing a mean index created by summing the values for the following 
variables and taking the mean of the sum: percent Black, percent Hispanic, percent with less than 
a high school education, percent unemployed, percent utilizing public assistance, percent of 
vacant properties, and percent with a poverty to income ratio below 2. The U.S. Census defines 
having an income-to-poverty ratio below 2 as being “poor or struggling”; thus we used 2.0 as our 
cut-point for the income-to-poverty ratio in the summary index. A factor analysis was used to 
confirm the construction of the summary variable.  The factor analysis showed that six of the 
seven variables loaded on to the same factor; percent Hispanic had a low loading value for the 
factor. Based on the factor analysis we then excluded percent Hispanic from the final summary 
index.  We were also interested in exploring the proportion of the block group that is foreign-
born. However, the ACS does not report these data for block groups.    
 This study was approved by the University of Michigan Institutional Review Board for 
Social and Behavioral Sciences and by the Michigan Department of Health and Human Services 
(MDHHS) Institutional Review Board.   
3.3.2 Genetic Cluster Definition  
 To classify cases as resulting from recent transmission, we followed previous methods 
that used both spoligotype and 12-locus-MIRU-VNTR results, as well as diagnostic dates38,64 to 
define genetically clustered TB cases. Clustered cases were those that shared an identical 
spoligotype and 12-locus-MIRU-VNTR result with at least one other case in the sample, and also 
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had a diagnostic data within one year of such a case. The addition of a time restriction into this 
definition allows for greater specificity in the classification of genetically clustered cases. 
Unique cases, or non-clustered cases, were those that either did not share an identical spoligotype 
and 12-locus-MIRU-VNTR result or did not have a diagnostic date within the one year time 
period.  
 Genetically clustered cases do not necessarily occur in spatial clusters. In addition, 
genetically clustered cases could become apparent after more than one year if they were 
connected by another case with an identical genotypic pattern with the one-year time frame. 
Genetically clustered cases were considered a proxy for those cases resultant from recent 
transmission; non-clustered were considered a proxy for those cases resultant from reactivation 
of LTBI.  
3.3.3 Statistical Analysis 
 To determine which individual- and neighborhood-level factors were significant 
predictors of TB clustering, we analyzed the prevalence of recently transmitted cases in relation 
to four classes of variables: demographic factors, known TB risk factors, clinical factors, and 
neighborhood characteristics of the block group. Demographic factors included: nativity, race, 
age, and sex. Known TB risk factors included: HIV status, alcohol use, diabetes, injecting drug 
use, non-injecting drug use, long-term care facility stay, and homelessness. Clinical risk factors 
included: immunosuppression, sputum-smear status, sputum-culture status, site of TB disease, 
and initial chest radiography results. Block-group characteristics included: population density, 
proportion of the population over 64 years of age, and a summary index of neighborhood 
disadvantage.  
 Univariate, modified Poisson regression models were used to examine the prevalence of 
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recent transmission with each of the risk factors individually. For data reduction, we then used 
stepwise regression models to determine which variables, when considered together, were the 
most significant predictors of transmission. Lastly, we constructed a final set of multivariable 
modified Poisson models that included the variables determined to be significant based on the 
step-wise regression model as well as based on a priori knowledge.  
 Our final multivariable regression models were modified Poisson models99 using 
generalized estimating equations (GEE) to account for nesting of cases within block groups. 
Such models allow for accurate parameter estimation and robust variance estimates by 
accounting for the correlated errors existing between cases in the same block group. The 
prevalence ratio and corresponding 95% confidence intervals were calculated using a Poisson 
regression model with a log link function.  
 Previous literature has suggested that the factors driving transmission are different for 
U.S.-born and foreign-born populations.46,92,100 Accordingly, we also stratified our models by 
nativity and reported the statistical models for U.S.-born and foreign-born persons separately. 
 For all analyses, we used an alpha level of 0.05 to signify significance. For the stepwise 
regression, we used an alpha level of 0.2 in order for a variable to be selected into the model and 
an alpha level of 0.05 for retention in the final step-wise regression model.  
3.4 Results 
3.4.1 Characteristics of the study sample  
 1,236 individuals were included in our final study sample (Table 3.8-1). The sample was 
23% Non-Hispanic White, 40% Non-Hispanic Black/African American, 25% Non-Hispanic 
Asian, 2% Non-Hispanic Other category, and 10% Hispanic. 72% of the sample was between the 
ages of 18-64 years. The sample was 60% male, 40% female. 45% of the sample was foreign-
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born; 55% U.S.-born. 94% of the sample was reported in a metropolitan county. 69% of the 
sample had primarily pulmonary TB, 22% primarily extra-pulmonary TB (EPTB), and 8% both 
pulmonary and EPTB.  
 477 (39%) of the 1,236 individuals were classified as a genetically clustered case while 
759 (61%) were classified as non-clustered. The 477 clustered cases belonged to 100 unique 
genetic clusters ranging in size from 2 to 49 cases. Another 6 individuals who were identified as 
part of clustered cases were singleton clusters because their counterparts were excluded from this 
study sample due to missing information on key covariates.  
 The proportion of clustering was significantly different comparing foreign-born and U.S.-
born individuals (P-value < 0.0001) (Table 3.8-2). 52% of the U.S.-born individuals were 
clustered compared to 22% of the foreign-born individuals.  
3.4.2 Regression analysis results  
 We investigated four classes of risk factors for being a clustered case of TB: demographic 
characteristics, known TB risk factors, clinical characteristics, and neighborhood characteristics. 
In the univariate models for the full sample there were 15 variables, across all four classes that 
were significant predictors of clustering. In particular, nativity was a significant risk factor for 
clustering in univariate models. The U.S.-born had a significantly higher prevalence of clustering 
compared to the foreign-born (P=<0.001) (Table 3.8-2). Based on these results and the 
methodology of previous studies, we decided to stratify our results on nativity, in addition to 
reporting results for the full sample.  
 For the foreign-born population, only two factors were significant predictors of clustering 
in univariate models: individual-level race and being a known contact of an infectious case of TB 
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(Table 3.8-4). These two factors retained their significant in the step-wise regression models and 
were the only two significant predictors in the final multivariable models. For the U.S.-born 
population, a wide range of factors were significant predictors of clustering in univariate models 
(Table 3.8-4).The step-wise regression model reduced the number of significant variables to age, 
sex, homelessness, known contact of an infectious case of TB, neighborhood density, and 
neighborhood disadvantage (results not shown).  
 Our final regression models included the variables identified in the step-wise regression 
models as well as race, sputum-smear status, and proportion of the neighborhood over 64 years 
of age.  However, while we included the same variables in the final models for both the U.S.-
born and foreign-born, the associations between each the factor and the prevalence of clustering 
was notably different for the two groups (Table 3.8-5). 
 In the final multivariable model for the U.S.-born, several factors were significant 
predictors of clustering: age, sex, known contact of an infectious case of TB, homelessness, 
density of the neighborhood, and neighborhood disadvantage after controlling for all other 
covariates in the model (Table 3.8-5). Those 65+ years had a 53% reduced prevalence of 
clustering compared to those 18-64 years (P < 0.0001). Males had a prevalence of clustering 1.19 
times greater than females (P < 0.05). The prevalence of clustering among those who were a 
known contact of an infectious case of TB was 1.27 times greater than those without such a 
contact (P < 0.05). Further, the prevalence of clustering among those who reported a history of 
homelessness in the past 12 months was 1.25 times greater than those who did not (P < 0.05). 
 For the U.S.-born, both neighborhood density and neighborhood disadvantage were 
significant predictors of clustering after controlling for all other covariates in the model. The 
prevalence of clustering for individuals living in the highest density neighborhoods was 1.31 
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times greater than for those living in the lowest density neighborhoods (Q4 vs Q1; P< 0.0001) 
(Table 3.8-5). The prevalence of clustering for individuals living in the most disadvantaged 
neighborhoods was 1.83 times greater than for those living in the least disadvantaged 
neighborhoods (Q4 vs Q1; P < 0.05). There also seemed to be a dose-response relationship in 
terms of neighborhood disadvantage—there was an increased prevalence of clustering for each 
quartile increase in neighborhood disadvantage. 
 In the final multivariable model for the foreign-born, non-Hispanic Asians had a 
prevalence of clustering 1.41 times greater than non-Hispanic Whites; Hispanics had a 
prevalence of clustering 2.03 times greater than non-Hispanic Whites (P < 0.05) (Table 3.8-5). 
Those that were a known contact of an infectious case of TB had a prevalence of clustering 1.8 
times greater than those without such a contact (P < 0.05).  
 Among the foreign-born we did not see an effect of the neighborhood environment on the 
prevalence of clustering. Differences in these observed effects between foreign-born and U.S.-
born were tested in the full sample using statistical interactions between nativity and 
neighborhood density and neighborhood disadvantage, as well as between nativity and race. In 
the multivariable model for the full sample, there was a significant interaction between nativity 
and neighborhood disadvantage (P< 0.001), but only marginally significant interaction between 
nativity and neighborhood density (P=0.10) and nativity and race (p=0.08). 
3.5 Discussion  
 This analysis identified factors that were significant predictors of clustering among TB 
cases identified by routine surveillance in the state of Michigan, 2004-2012. We used genotypic 
clustering as a proxy for cases resulting from recent transmission. We found that the factors 
predicting recent transmission for the foreign-born were notably different than those for the U.S.-
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born, with the exception of being a known contact of an infectious case of TB. For the U.S.-born, 
recent transmission was influenced more by individual-level and neighborhood-level socio-
demographic factors than by clinical risk factors. While clinical factors and traditional TB risk 
factors were associated with TB transmission in univariate models, few retained significance in 
multivariable models. Our findings point to the importance of the social and physical context of 
people in influencing TB transmission in a high-disparity environment, particularly among U.S.-
born populations.  
 Our findings further shed light on the difference between foreign-born and U.S.-born 
populations and their risk of TB.  52% of the U.S.-born cases of TB resulted from recent 
transmission, compared to 22% of foreign-born cases. Thus, among the foreign-born, perhaps the 
greatest concern in TB control should be reducing the rate of reactivation of LTBI.  For the 
foreign-born populations, the risk of TB is likely related to the prevalence of TB in their country 
of origin—those emigrating from high-burden TB settings may be infected in their country of 
origin and reactivate once in the U.S.81–83 While there is mandatory screening for foreigners 
applying for immigration status for active TB and LTBI, this screening only applies to those 
applying for permanent visas in the U.S., missing the large proportion of legal immigrants 
applying for temporary visas.101 TB control strategies for this population should be targeted at 
diagnosing cases of LTBI before reactivation has occurred—this would also reduce transmission 
in these populations.  
 In the foreign-born analysis we saw that Asians had an increased prevalence of recent 
transmission compared to Whites. This is after controlling for measures of the neighborhood 
environment and other social risk factors. More work is needed to understand how the Asian 
population as a whole differs from other foreign-born populations. It may be that Asian 
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immigrants are more likely to live in closer proximity to one another or in multi-family housing. 
Future studies should seek to better understand what is driving this disparity. Additionally, future 
studies would benefit from disaggregating the Asian racial group into the ethnically diverse 
groups that compose it. This may also facilitate a better understanding of what is driving recent 
transmission in this population.  
 The observed differences in the effects of race and neighborhood density between the 
foreign-born and U.S.-born were not statistically different, precluding any firm conclusions 
about different patterns in incidence by nativity. However, the differences in the effect of 
neighborhood socioeconomic disadvantage by nativity were statistically supported, suggesting 
there are notable effects of the residential environment on TB transmission even after adjusting 
for individual risk factors for the U.S.-born. Several studies have found evidence of higher TB 
rates in socially disadvantaged neighborhoods.54,102,103 However, few studies have reported such 
stark differences in the effects of the neighborhood environment by nativity. In her 2000 paper 
on residential segregation and TB, Acevedo-Garcia posits there are both direct and indirect 
pathways by which the neighborhood environment may influence TB risk.104  Directly, the 
neighborhood environment can pattern a) the spatial distribution of susceptible and infectious 
cases, b) the contact patterns between these groups, and c) the density of the susceptible pool.104 
The likelihood of transmission of TB is a function of the size of the susceptible pool and how 
densely such susceptibles are distributed in a given space.105–107 In our study, we were able to 
examine neighborhood density specifically and found that it was a significant predictor of 
transmission among the U.S.-born—even after controlling for neighborhood disadvantage. This 
finding makes sense given that the U.S.-born population had a higher prevalence of transmission 
of TB. Thus, an active case of TB in a high-density neighborhood will result in a greater number 
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of secondary cases than if the case were in a low-density neighborhood.  
 We also found evidence of the indirect influence of the neighborhood on TB transmission 
among the U.S-born. We observed a neighborhood-level disadvantage gradient in the prevalence 
of recently transmitted TB whereby those living in more disadvantaged neighborhoods had an 
increased prevalence of recent transmission. Previous studies have found a similar gradient both 
in incidence of TB overall,44,103 as well as specifically for transmission.46 Notably, our finding of 
the SES gradient in TB transmission only held true among the U.S.-born which is consistent with 
a study that reported that neighborhood-level gradients in disadvantage were steeper for the U.S-
born.100  
 In univariate models among the U.S.-born, both Blacks and Hispanics were at higher risk 
for TB transmission compared to Non-Hispanic Whites. This disparity was attenuated in 
multivariable models. Such models showed that neighborhood-level disadvantage was a more 
meaningful predictor of recent transmission than individual-level race in this population. This 
lends support to the fact that race is only a meaningful predictor of recent TB transmission 
insomuch as it is evidence of a much larger social pattern.  In the case of TB, individual-level 
race is likely a proxy for disadvantage, and more specifically in our study, neighborhood-level 
disadvantage.  
 Other studies have also reported that the effects of the neighborhood environment depend 
on the race and ethnicity of the individual.46,92,100,108 It may be that the neighborhood 
environment has different meanings, and confers different risks, depending on an individual’s 
racial and ethnic identity. In the U.S., the neighborhood in which a person resides is not only 
indicative of the physical environment to which one is exposed but it also reflects a much deeper 
social history tied very closely to one’s social identity. Thus, the neighborhood environment can 
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indirectly pattern the distribution of TB through such mechanisms as poverty, housing 
conditions, social disorganization, access to health care,104 and political disinvestment.  
Moreover, Acevedo-Garcia argues that the quality of the social and physical environment are a 
result of larger structural influences such as structural racism and residential segregation, 
influences inextricably tied to individual-level race/ethnicity.61 Structural influences such as 
residential segregation have been at work since early in the 20th century—systematically putting 
minority populations at risk.109 Urban renewal and development efforts of the 1900s 
systematically benefited Whites while displacing minority populations resulting in minority 
communities with greater proportions of low quality housing, dilapidation, and material resource 
deprivation.104 However, in addition to the lack of material resources, it is also the enduring 
stress of living in such an environment where one is continually exposed to structural 
disadvantage that can produce worse health outcomes for these populations110–112 Such 
conditions have created silent epidemics whereby rates of diseases, such as TB are permitted to 
continue in isolated communities because those who are politically and socially advantaged are 
shielded from the enduring effects of the disease. Based on our findings, and consistent with 
other U.S.-based studies, transmission of TB is happening in insular communities defined by 
their socio-demographic make-up and hidden from their more advantaged counterparts.92  
 This framework also helps explain why we do not observe these same patterns in the 
foreign-born population. Only 28% of the foreign-born population lived in a disadvantaged 
neighborhood (above the median level of disadvantage); this is compared to 67% of the U.S.-
born population. While some immigrant populations are likely to live in poor areas and be 
subject to extreme poverty, in our population seem to be of a higher SES class than the U.S.-born 
population. Further, even for those the foreign-born persons who may be living in disadvantaged 
  
 54 
environments, these environments do not hold the same risk as they do for U.S.-born 
populations.  
 For both groups, being a known contact of an infectious case of TB was a significant risk 
factor for transmission of TB. This finding points to the success of current policies and 
procedures implemented at state and local health departments on active TB case findings. When 
an infectious case of TB is found, often the local health department will initiate a screening of all 
known contacts of the individual. The finding that those who are a known contact of an 
infectious case of TB are at greater risk for transmission is further proof that such a strategy is 
critical to identifying those at risk for transmission.  
3.6 Limitations  
 There are several limitations to our study that should be considered in the interpretation 
of our study findings. First, inferences regarding individual-level risk based on group-level 
factors are vulnerable to the ecological fallacy. However, we are not assuming a causal 
relationship between neighborhood level factors and one’s individual risk of TB transmission. 
Rather, we are making assumptions about the spaces and environments that might make one 
more or less susceptible to disease.   
 There were also limitations due to the exclusion criteria applied to derive the final study 
sample.  Our analyses were contingent upon the availability of genotypic data and thus we 
excluded cases that were diagnosed based on clinical criteria, without culture confirmation. This 
could bias our results and could lead to underestimation of the association between each variable 
and prevalence of clustering if the clinical cases are significantly different than the culture-
positive cases included in the analysis.  
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 We only examined predictors of transmission within a sample of TB cases. Thus, it is 
plausible there are important predictors of TB transmission that are missed without comparisons 
to the larger TB-free population. A 2008 study used the 1999-2000 NHANES to estimate the 
national prevalence of LTBI. They estimated the prevalence of LTBI in the U.S. to be 4.8% (11, 
213, 000).90 Of those with LTBI, 5-10% will develop active disease sometime in their lifetime.5,8 
Our findings, therefore, may be generally applicable to the subset of those with LTBI who may 
reactivate and then subsequently be at risk to transmit the pathogen to susceptible individuals. 
 Additionally, while we believe that the addition of a time-restriction component adds 
greater specificity to our classification of recent transmission, there is a still the possibility of 
misclassification. However, we believe such misclassification would be non-differential and 
would bias any observed results towards the null.  
 Finally, the address information extracted from the RVCT form may not accurately 
capture the address for all individuals. Moreover, we excluded those without address 
information. This systematically leaves out the homeless population. However, the proportion of 
the study population without an address was less than 10% of the entire TB population and 
therefore, we do not believe such an exclusion significantly biased our findings. It is likely that 
any bias that would occur from such an exclusion is a bias towards the null, underestimating the 
true prevalence of clustering.   
3.7 Conclusions  
 Our findings point to the need to consider the socio-economic context of individuals in 
designing interventions aimed at reducing transmission of TB. While a focus on individual-level 
factors, whether in our research studies or TB control strategies, may have been sufficient to 
reduce the incidence of TB in the U.S. overall in the last decades, such a focus is insufficient to 
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addressing enduring disparities in TB incidence, largely patterned along lines of social 
disadvantage. Reducing disparities in TB incidence, and particularly in TB transmission, will 
require strategies that can target high-risk groups and allocate resources effectively. 
Additionally, it may be that high-risk needs to be defined based on ecologic factors such as 
neighborhood poverty,61 rather than on individual-level factors. Only then will TB elimination in 
the U.S. be possible in the foreseeable future.  
  
 57 
3.8 Tables 
Table 3.8-1 Comparison of the distribution of selected demographic and clinical characteristics 
among all TB cases (n=1,800) and the study sample (n=1,236) in Michigan, 2004-2012. 
 
  
Total TB Cases 
(n=1,800)   
Study Sample 
(n=1,236)  
  No. %   No. % 
Race           
Non-Hispanic White 439 24.39   285 23.06 
Non-Hispanic Black/African American 706 39.22   497 40.21 
Non-Hispanic Asian 423 23.5   304 24.6 
Non-Hispanic Other 38 2.11   28 2.27 
Hispanic 194 10.78   122 9.87 
Age (years)            
<18 124 6.88   35 2.83 
18-64 1263 70.16   891 72.09 
65+ 413 22.94   310 25.08 
Sex            
Male 1047 58.2   735 59.51 
Female 752 41.8   500 40.49 
Missing 1     1   
Nativity            
Foreign-born 798 44.48   553 44.81 
U.S.-born 996 55.52   681 55.19 
Missing 6     2   
Geographic area            
Metro 1690 94.05   1158 93.69 
Micro 49 2.73   39 3.16 
Rural 9 0.5   5 0.4 
Unknown 49 2.73   34 2.75 
Missing           
Site of disease           
Pulmonary 1188 66.22   855 69.29 
Extrapulmonary 463 25.81   277 22.45 
Both 143 7.97   102 8.27 
Missing 6     2   
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Table 3.8-2  2x2 table comparing the proportion of clustering among foreign-born and U.S.-born 
populations. 
 
 
 
  
 
Clustered 
# (%) 
Non-Clustered 
# (%) 
Total 
Foreign-born 121 (22) 432 (78) 553 
U.S.-born 354 (52) 327 (48) 681 
Total 475 759 1234 
P-value < 0.0001 based on the Chi-Square test. 
*2 individuals were missing data on nativity 
  
 59 
Table 3.8-3 Comparison of the distribution of selected covariates between clustered and non-
clustered TB cases.  
    
Clustered 
Cases  
Non-Clustered 
Cases  
P-Value  
    N % N %   
Total  
 
477 38.59 759 61.41 
 Demographic Factors  
   
   Nativity  
   
   U.S.-born 
 
354 74.21 327 43.08 <0.0001 
Foreign-born 
 
121 25.37 432 56.92 
 Missing  
 
2 0.42 0 0 
 Race  
     
 Non-Hispanic White  
 
74 15.51 211 27.8 <0.0001 
Non-Hispanic Black  
 
277 58.07 220 28.99 
 Asian  
 
78 16.35 226 29.78 
 Other  
 
11 2.31 17 2.24 
 Hispanic  
 
37 7.76 85 11.2 
 Age (years)  
     
 <18  
 
18 3.77 17 2.24 <0.0001 
 18-64 
 
391 81.97 500 65.88 
 65+ 
 
68 14.26 242 31.88 
 Sex 
     
 Male  
 
308 64.57 427 56.26 0.0059 
Female  
 
168 35.22 332 43.74 
 Missing  
 
1 0.21 0 0 
 Geographic Location  
     
 Metro  
 
459 96.23 699 92.09 0.0224 
Micro  
 
10 2.1 29 3.82 
 Rural  
 
2 0.42 3 0.4 
 Unknown  
 
6 1.26 28 3.69 
 Known TB Risk Factors  
     
 Diabetes  
     
 Diabetes   
 
23 4.82 46 6.06 0.3558 
No Diabetes  
 
454 95.18 713 93.94 
 HIV  
     
 HIV Test Positive  
 
40 8.39 29 3.82 0.0024 
HIV Test Negative  
 
313 65.62 477 62.85 
 HIV Test Not Done 
 
71 14.88 144 18.97 
 HIV Test Refused 
 
39 8.18 82 10.8 
 HIV Test Unknown  
 
14 2.94 27 3.56 
 Alcohol Use 
     
 Alcohol Use 
 
86 18.03 66 8.7 <0.0001 
No Alcohol Use  
 
365 76.52 670 88.27 
 Missing 
 
26 5.45 23 3.03 
 Injecting Drug Use (IDU) 
     
 IDU Use 
 
27 5.66 12 1.58 <0.0001 
No IDU Use 
 
428 89.73 732 96.44 
 Missing  
 
22 4.61 15 1.98 
 Non-Injecting Drug Use (IDU) 
   
 Non-IDU Drug Use  
 
68 14.26 33 4.35 <0.0001 
No Non-IDU Drug Use 
 
381 79.87 707 93.15 
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Missing  
 
28 5.87 19 2.5 
 Stay in a Long-Term Care (LTC) Facility  
 
 LTC Stay  
 
20 4.19 27 3.56 0.8093 
No LTC Stay  
 
454 95.18 726 95.65 
 Missing  
 
3 0.63 6 0.79 
 Homelessness 
     
 Homeless  
 
47 9.85 23 3.03 <0.0001 
Not Homeless  
 
420 88.05 729 96.05 
 Missing  
 
10 2.1 7 0.92 
 Incarceration in last 12 months 
   
 Incarcerated  
 
11 2.31 9 1.19 0.2736 
Not Incarcerated  
 
464 97.27 745 98.16 
 Missing  
 
2 0.42 5 0.66 
 Directly Observed Therapy Time  
  
 < 18 weeks 
 
81 16.98 134 17.65 0.1537 
19-25 weeks 
 
67 14.05 129 17 
 26-31 weeks 
 
90 18.87 169 22.27 
 > 31 weeks 
 
99 20.75 129 17 
 DOT Missing  
 
140 29.35 198 26.09 
 Known Contact of an Infectious TB Case 
   
 Infectious contact 
 
53 11.11 35 4.61 <0.0001 
No Infectious Contact 
 
424 88.89 724 95.39 
 Incomplete Latent TB Infection (LTBI) Treatment  
  
 Incomplete LTBI  
 
6 1.26 12 1.58 0.6443 
No Incomplete LTBI   
 
471 98.74 747 98.42 
 Clinical Risk Factors  
     
 End Stage Renal Disease 
     
 ESRD  
 
2 0.42 4 0.53 0.7908 
No ESRD 
 
475 99.58 755 99.47 
 Organ Transplant or TNF-a Antagonist Therapy  
 
 Transplant/Therapy  
 
11 2.31 11 1.45 0.2674 
No Transplant/Therapy   
 
466 97.69 748 98.55 
 Immunosuppression  
     
 Immunosuppression  
 
14 2.94 21 2.77 0.8622 
No Immunosuppression 
 
463 97.06 738 97.23 
 Sputum-Smear (SS) Status  
     
 SS Positive 
 
251 52.62 305 40.18 <0.0001 
SS Negative  
 
122 25.58 212 27.93 
 SS Not Done  
 
102 21.38 241 31.75 
 SS Unknown  
 
2 0.42 0 0 
 SS Missing  
 
0 0 1 0.13 
 Sputum-Culture (SC) Status  
     
 SC Positive 
 
339 71.07 441 58.1 <0.0001 
SC Negative 
 
32 6.71 60 7.91 
 SC Not Done 
 
106 22.22 252 33.2 
 SC Unknown 
 
0 0 5 0.66 
 SC Missing  
 
0 0 1 0.13 
 Site of TB Disease 
     
 Pulmonary TB (PTB) Only  
 
359 75.26 496 65.35 0.0012 
Extra-Pulmonary TB (EBTB) Only 
 
81 16.98 196 25.82 
 Both PTB and EPTB 
 
37 7.76 65 8.56 
 Missing  
 
0 0 2 0.26 
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Initial Chest Radiography (X-Ray) 
     
 Normal Chest X-Ray 
 
51 10.69 127 16.73 0.0101 
Abnormal Chest X-Ray 
 
407 85.32 591 77.87 
 Chest X-Ray Not Done 
 
16 3.35 37 4.87 
 Chest X-Ray Unknown 
 
3 0.63 2 0.26 
 Missing 
 
0 0 2 0.26 
        Block Group Characteristics  
          Density  
   Q1 
 
96 20.13 213 28.06 <0.0001 
Q2 
 
113 23.69 196 25.82 
 Q3 
 
116 24.32 193 25.43 
 Q4 
 
152 31.87 157 20.69 
 Proportion of Population Over 64 Years   
Q1  118 24.74 191 25.16 0.5887 
Q2  117 24.53 192 25.30  
Q3  113 23.69 196 25.82  
Q4  129 27.04 180 23.72  
Index of Neighborhood Disadvantage  
   Q1 
 
70 14.68 239 31.49 <0.0001 
Q2 
 
79 16.56 230 30.3 
 Q3 
 
135 28.3 175 23.06 
 Q4 
 
193 40.46 115 15.15 
 
              
Q = Quartile  
      Results based on chi-square test comparing the distribution of covariates among 
clustered and non-clustered TB cases.  
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Table 3.8-4 Results of univariate Poisson regression models estimating the prevalence of 
clustered cases for each single factor for the sample overall and U.S.-born and foreign-born 
separately.    
 
Overall U.S.-Born Foreign-Born  
 
Prevalence Ratio 
(95% CI)  
Prevalence Ratio 
(95% CI)  
Prevalence Ratio 
(95% CI)  
Demographic Factors  
 
    
Nativity  
 
    
U.S.-born vs FB 2.38 (2.00, 2.83)**      
Race        
NH-Asian vs. NH-White  1.51 (0.92, 2.50)** 0.79 (0.23, 2.66)**  2.54 (1.28, 5.03)* 
NH-Black vs NH-White  2.15 (1.74, 2.66)  1.96 (1.58, 2.43) 1.35 (0.55, 3.29)  
NH-Other vs NH-White  1.51 (0.92, 2.50)  1.58 (0.95, 2.61)  1.98 (0.49, 8.03) 
Hispanic vs NH-White  1.17 (0.84, 1.63)  1.73 (1.11, 2.71)  2.52 (1.21, 5.25) 
Age (in years)       
<18 vs 18-64 1.17 (0.84, 1.63)**  1.05 (0.76, 1.47)** 1.57 (0.81, 3.06)  
65+ vs 18-64 0.50 (0.40, 0.62)  0.39 (0.30, 0.50) 0.79 (0.51, 1.22) 
Sex       
Male vs Female  1.25 (1.07,1.45)*  1.29 (1.10, 1.52)* 0.93 (0.68, 1.28)  
Known TB Risk Factors        
Diabetes        
Diabetes vs No Diabetes  0.86 (0.61, 1.20) 0.78 (0.52, 1.18)  1.08 (0.58, 2.02)  
HIV        
HIV+  vs HIV -  1.46 (1.17, 1.82)*  1.22 (1.0, 1.50)** 1.30 (0.60, 2.80)  
HIV Not Done vs HIV -  0.83 (0.68, 1.03)  0.74 (0.59, 0.92)  0.87 (0.53, 1.42) 
HIV Unknown vs HIV - 0.86 (0.56, 1.33) 0.67 (0.40, 1.13)  1.17 (0.49, 2.79)  
HIV Refused vs HIV - 0.81 (0.62, 1.07)  0.69 (0.49, 0.96)  1.24 (0.79, 1.95)  
Alcohol Use       
Alcohol Use vs None  1.60 (1.36, 1.89)**  1.26 (1.08, 1.48)*  0.94 (0.38, 2.29) 
Injecting Drug Use (IDU)       
IDU vs None 1.88 (1.50, 2.34)**  1.37 (1.09, 1.73)*  3.16 (1.40, 7.15)*   
Non-Injecting Drug Use (Non-IDU)       
Non-IDU Use vs None  1.92 (1.64, 2.25)** 1.45 (1.24, 1.70)** 1.36 (0.42, 4.43)  
Long-Term Care Facility        
LTC vs No LTC  1.11 (0.79, 1.55)  0.81 (0.57, 1.16)  1.84 (0.62, 5.44)  
Homelessness       
Homeless vs Not  1.84 (1.53, 2.20)** 1.62 (1.38, 1.89)**  0.91 (0.33, 2.53) 
Incarceration        
Incarcerated vs Not  1.43 (0.96, 2.14)  1.11 (0.75, 1.64)  NA  
DOT Therapy Time        
< 18 wks vs > 31 wks  0.87 (0.69, 1.09) 0.77 (0.60, 0.98)  1.22 (0.73, 2.01)  
26-31 wks vs > 31 wks  0.80 (0.64, 1.00) 0.90 (0.72, 1.13)  0.89 (0.54, 1.47)  
19-25 wks vs > 31 wks  0.79 (0.62, 1.01)  0.82 (0.63, 1.07)  1.08 (0.66, 1.78)  
DOT missing vs > 31 wks 0.96 (0.79, 1.16) 0.90 (0.75, 1.09)  0.82 (0.48,1.42)  
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Infectious Contact        
Infectious contact vs Not  1.63 (1.35, 1.96)**  1.34 (1.11, 1.63)*  2.18 (1.40, 3.37)**  
Incomplete LTBI Treatment        
Incomplete LTBI vs Not  0.86 (0.45, 1.66)  1.07 (0.59, 1.92)  0.50 (0.08, 3.22) 
Clinical Risk Factors        
End Stage Renal Disease (ESRD)       
ESRD vs Not  0.86 (0.28, 2.68)  0.64 (0.13, 3.17)  1.53 (0.31, 7.63) 
Organ Transplant or TNF-a Antagonist 
Therapy  
      
Transplant/Therapy vs Not  1.30 (0.85, 1.99) 1.12 (0.69, 1.82)  1.54 (0.60, 3.92)  
Immunosuppression       
Immuno-suppressed vs Not  1.04 (0.69, 1.57) 0.75 (0.45, 1.25)   1.94 (0.98, 3.87)  
Sputum-Smear Status        
SSP vs SSN  1.24 (1.04, 1.46)**  1.15 (0.96, 1.37)* 1.00 (0.70, 1.44)  
SSND vs SSN  0.82 (0.66, 1.01)  0.80 (0.63, 1.02)  0.78 (0.52, 1.19)  
SS Unknown vs SSN  2.74 (2.38, 3.15)  1.98 (1.69, 2.30) NA 
Site of TB Disease       
PTB vs EPTB  1.43 (1.17, 1.75)**  1.13 (0.92, 1.40)  1.44 (0.98, 2.12)  
Both PTB/EPTB vs EPTB Only 1.24 (0.90, 1.70) 1.32 (0.97, 1.79)  1.00 (0.52, 1.92)  
Initial Chest Radiography        
Abnormal vs Normal  1.42 (1.12, 1.82)*  1.04 (0.81, 1.33)  1.64 (1.01, 2.66)  
Not Done vs Normal  1.05 (0.66, 1.69)  0.87 (0.53, 1.43) 1.01 (0.37, 2.77)  
Unknown vs Normal  2.09 (0.99, 4.44)  0.56 (0.57, 3.02)  3.41 (0.79, 14.64)  
Block Group Characteristics        
Density        
Q2 vs Q1  1.11 (0.87, 1.42)**  1.19 (0.90, 1.57)** 1.05 (0.68, 1.62) 
Q3 vs Q1  1.24 (0.98, 1.56) 1.38 (1.06, 1.79) 0.92 (0.59, 1.43) 
Q4 vs Q1  1.65 (1.33, 2.04)  1.85 (1.47, 2.34)  0.95 (0.60, 1.49) 
Proportion Over 64 Years         
Q2 vs Q1  0.97 (0.79, 1.20) 0.90 (0.73, 1.11)  0.82 (0.55, 1.22) 
Q3 vs Q1  0.93 (0.75, 1.15) 0.80 (0.64, 0.99) 0.76 (0.47, 1.25) 
Q4 vs Q1  1.03 (0.83, 1.27) 0.83 (0.67, 1.03) 1.14 (0.77, 1.69) 
Index of Neighborhood Disadvantage        
Q2 vs Q1  1.13 (0.85, 1.50)**  1.58 (1.02, 2.44)** 0.86 (0.59, 1.26) 
Q3 vs Q1  1.92 (1.52, 2.44) 2.72 (1.86, 3.98) 0.83 (0.54, 1.27) 
Q4 vs Q1  2.76 (2.21, 3.44)  2.85 (1.96 (4.14)  1.42 (0.89, 2.27) 
    Results are based on univariate Poisson regression models  
All models are adjusted for all other covariates 
* indicates a P-value ≤ 0.05 based on type 3 effects  
** indicates a P-value ≤ 0.001 based on type 3 effects  
SSP = Sputum-Smear Positive; SSN= Sputum-Smear Negative; SSND = Sputum-Smear Not Done 
PTB = pulmonary TB; EPTB = Extra-pulmonary TB 
  
NA = not application due to a lack of cases within levels of the variables 
Q = quartile  
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Table 3.8-5 Results of final multivariable Poisson regression models estimating the prevalence 
of clustering for the sample overall and U.S.-born and foreign-born separately.    
  
Overall 
(N=1,336) 
U.S.-Born 
(N=681) 
Foreign-Born 
(N=553)  
 
Prevalence Ratio 
(95% CI)  
Prevalence Ratio 
(95% CI)  
Prevalence Ratio 
(95% CI)  
Demographic Factors        
Nativity     
U.S.-born vs. Foreign-born 2.61 (2.01, 3.40)**   
Race      
 
Non-Hispanic Asian vs. Non-Hispanic White  2.0 (1.42, 2.80)* 0.59 (0.18, 1.90) 2.41 (1.22, 4.75)* 
Non-Hispanic Black vs Non-Hispanic White  1.32 (1.05, 1.65)  1.20 (0.95, 1.53) 1.22 (0.48, 3.06) 
Other vs Non-Hispanic White  1.36 (0.77, 2.43) 1.22 (0.63, 2.36) 1.87 (0.46, 7.58) 
Hispanic vs Non-Hispanic White  1.54 (1.11, 2.14) 1.33 (0.90, 1.97) 2.03 (0.95, 4.35) 
Age (in years)     
 
<18 vs 18-64 1.04 (0.75, 1.45)** 1.09 (0.81, 1.46)** 1.52 (0.74, 3.13) 
65 + vs 18-64  0.55 (0.44, 0.69) 0.47 (0.36, 0.61) 0.83 (0.52, 1.33) 
Sex     
 
Male vs Female 1.12 (0.97, 1.30) 1.19 (1.02, 1.39)* 0.89 (0.64, 1.23) 
Clinical Characteristics        
Sputum-Smear     
 
SSP vs SSN  1.06 (0.91, 1.24) 1.07 (0.91, 1.26) 1.02 (0.71, 1.47)  
SSND vs SSN 0.90 (0.73, 1.10) 0.98 (0.799, 1.22) 0.77 (0.51, 1.18)  
Known TB Risk Factors       
Infectious Contact      
 
Infectious contact vs Not  1.36 (1.13, 1.65)* 1.27 (1.04, 1.54)*  1.80 (1.83, 2.74)*  
Homeless      
 
Homeless vs Not  1.24 (1.06, 1.44)* 1.25 (1.08, 1.45)* 0.78 (0.27, 2.24)  
Block Group Characteristics       
Density      
 
Q2 vs Q1  0.94 (0.77,1.15)* 0.90 (0.72, 1.14)**  0.99 (0.64, 1.52) 
Q3 vs Q1  1.0 (0.82, 1.22) 1.03 (0.83, 1.29) 0.93 (0.59, 1.46)  
Q4 vs Q1  1.22 (1.00, 1.48) 1.31 (1.06, 1.62) 0.85 (0.52, 1.41)  
Proportion of Population over 64 Years     
 
Q2 vs Q1  0.97 (0.82,1.17)* 1.06 (0.87, 1.29) 0.88 (0.59, 1.31)  
Q3 vs Q1  0.95 (0.78, 1.15) 1.01 (0.83, 1.24) 0.78 (0.47, 1.29)  
Q4 vs Q1  1.19 (0.99, 1.42) 1.16 (0.96, 1.41) 1.22 (0.79, 1.88)  
Index of Neighborhood Disadvantage      
 Q2 vs Q1  1.02 (0.78, 1.35)* 1.37 (0.89, 2.10)* 0.93 (0.64, 1.36)  
Q3 vs Q1  1.28 (0.99, 1.66) 1.75 (1.15, 2.67) 0.93 (0.59, 1.48)  
Q4 vs Q1  1.47 (1.12, 1.92) 1.83 (1.21, 2.76) 1.56 (0.89, 2.74)  
        
Results are based on multivariable Poisson regression models  
All models are adjusted for all other covariates 
* indicates a P-value ≤ 0.05 based on type 3 effects  
** indicates a P-value ≤ 0.001 based on type 3 effects  
SSP = Sputum-Smear Positive; SSN= Sputum-Smear Negative; SSND = Sputum-Smear Not Done 
Q = quartile 
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Table 3.8-6 Supplementary table comparing the distribution of key covariates among cases with 
address information and those without address information. 
 
Cases with 
Address 
Information  
Cases Missing 
Address 
Information  P-Value  
 
# % # % 
 Total Cases = 1,800 1,696 94.22 104 5.78 
 Race           
White 579 34.14 39 37.5 <0.0001 
Black/African American 677 39.92 44 42.31 
 
Asian 410 24.17 18 17.31 
 
American Indian/Alaskan 
Native 
5 0.29 0 0 
 
Native Hawaiian 3 0.18 0 0 
 
Other 11 0.65 0 0 
 
Unknown 11 0.65 0 0 
 
Missing 0 0 3 2.88   
Age (years)  
     
<18 117 6.9 7 6.73 0.7782 
18-64 1187 69.99 76 73.08 
 
65+ 392 23.11 21 20.19   
Sex  
  
  
  
Male 976 57.55 71 68.27 0.0971 
Female 719 42.39 33 31.73 
 
Missing 1 0.06 0 0   
Nativity  
   
  
 
Foreign-born 759 44.75 39 37.5 <0.0001 
US-born 935 55.13 61 58.65 
 
Missing 2 0.12 4 3.85   
Geographic area  
     
Metro 1596 94.10 94 90.38 <0.0001 
Micro 46 2.71 3 2.88 
 
Rural 8 0.47 1 0.96 
 
Unknown 46 2.71 3 2.88 
 
Missing 0 0.00 3 2.88   
Site of disease 
     
Pulmonary TB (PTB) Only 1116 65.80 72 69.23 <0.0001 
Extrapulmonary TB (EPTB) 
Only 
441 26.00 22 21.15 
 
Both PTB and EPTB 137 8.08 6 5.77 
 
Missing 2 0.12 4 3.85   
  
     Results based on chi-square test comparing the distribution of covariates among cases with 
address information and those without address information.  
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CHAPTER 4. THE SOCIO-DEMOGRAPHIC 
CHARACTERISTICS OF TUBERCULOSIS CASES IN 
METRO DETROIT 
4.1 Background & Rationale  
 There is a long history of stark disparities in TB along lines of social disadvantage in the 
U.S.  Despite the ubiquity of TB exposure during the 19th and early-20th centuries, TB 
disproportionately burdened certain subpopulations, namely racial/ethnic minorities and 
immigrants. The disparities in TB existed not only in terms of who was exposed to and 
developed TB but also in terms of who received treatment. Sanatoriums—popular in the early 
1900s –were reserved almost exclusively for White, U.S.-born individuals.31 Moreover, the 
subsequent declines in TB incidence throughout the 20th century were disproportionately 
concentrated in the most advantaged groups.  
 The disparities in TB incidence have persisted into current time—nationally, TB still 
disproportionately affects the foreign-born, racial/ethnic minorities, the poor, those living in 
urban environments, the homeless, and the incarcerated.35,39,40 Our findings in Michigan further 
shed light on persistent and pervasive disparities, particularly along lines of race and nativity. 
From 2004-2012, Blacks had an average incidence 19 times greater than Whites among cases of 
recently transmitted tuberculosis (TB) (Aim 1)—this is compared to 6 times greater incidence in 
Blacks versus Whites nationally.35 The foreign-born had an average incidence 19 times greater 
than the U.S.-born among cases of reactivation of latent TB infection (LTBI) (Aim 1). In our 
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analysis of risk factors for recently transmitted TB, markers of social vulnerability such as 
foreign-born nativity, minority race status, homelessness, drug use, stay in a long-term care 
facility were consistently the most significant predictors of TB transmission compared to clinical 
characteristics (Aim 2).  
 Despite evidence of significant disparities, data on the trends and distribution of TB are 
mainly focused on reporting of surveillance trends, and mostly at a national level. While there is 
an acknowledgement of the disparities in TB incidence among certain subgroups (i.e. minorities 
and socio-economically disadvantaged), there is a lack of work that aims to understand these 
trends and the mechanisms underlying them. Such a focus on national trends without careful 
attention to the systems creating and allowing disparities to exist may inadvertently give those 
involved in TB control a false sense of hope. While the absolute burden of disease has decreased 
in recent decades, disparities in incidence have increased. In the 1989 Strategic Plan for the 
Elimination of Tuberculosis in the United States, the CDC put forth a hypothesis that TB could 
be eliminated in the U.S. by 2010 because it was concentrated in “geographically and 
demographically defined pockets.”104,113 While this assertion by the CDC that TB has moved 
from being a disease common in the population to concentrated in disadvantaged populations is 
accurate, assertions such as this neglect the rising disparities that continue to persist in TB 
distribution among disadvantaged populations, particularly minority and foreign-born 
populations.  In her paper on the links between residential segregation and infectious disease, 
Acevedo-Garcia argues that as public health professionals it is unacceptable for rising disparities 
to be tolerated even if the overall burden of disease is declining.104 Further, she argues that 
residential segregation shields more advantaged groups from recognizing the continuing impact 
of TB, reducing incentives to address the disease.104 Regardless of the national trends in TB 
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incidence, the concentration of TB in geographically and demographically confined groups 
creates conditions for disparities in TB to persist. 
 In addition to the focus on national aggregate trends, current TB studies tend to report 
single-factor descriptions rather than multivariable analyses that can account for complex 
relationships between variables. Few studies have offered a more thorough explanation of how 
social factors such as race, nativity, sex, and age may be working together to augment risk. For 
example, our findings in Aim 1 of this dissertation demonstrated a significant suppression effect 
of race by nativity. In a single regression model with only race, the disparity between Asian and 
Whites was greater than the disparity between Blacks and Whites. When nativity was included in 
the regression model, the disparity between Asians and Whites reduced by nearly 40%, while the 
disparity between Blacks and Whites increased making Blacks the highest risk racial group (Aim 
1). In her study of residential segregation and TB, Acevedo-Garcia suggests that delineation of 
single risk factors without attention to the systems and mechanisms in which they operate 
actually precludes TB researchers from understanding the true epidemiology of TB.104,114 Single-
factor analyses likely miss important relationships that exist between social variables. 
 Both historical and contemporary evidence highlight the social patterning of TB, yet 
there is a scarcity of research explicitly aimed at understanding the pathways by which the social 
determinants of health are associated with TB. This is driven, in part by, a lack of detailed socio-
demographic data on TB patients. Much of what we know about the social experience of TB 
patients in the U.S. is derived from evidence (both formal and anecdotal) decades old. To date, 
very few studies have been able to ascertain detailed socio-demographic data on TB patients. 
Researchers in Houston, TX sought to gather more in-depth data on TB patients by administering 
a survey in a population-based study of actively enrolled cases in order to assess the association 
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of ethnicity and the risk of being a recently transmitted cases of TB in this population.115 
Interestingly, they found that markers of socio-economic status such as education, employment, 
and income, and not ethnicity and nativity, were more significant predictors of being a recently 
transmitted case of TB.115 Their study was focused on risk factors for transmission rather than 
documenting disparities in general TB disease, and was limited in the scope of variables 
considered. However, their findings point to the feasibility and need for studies that can gather 
more in-depth information on the social characteristics of TB cases.   
 Employing a social determinants of health framework is necessary to not only understand 
the patterns of incidence and disparities in TB, but also to design interventions that can focus 
resources on the most at-risk groups. Current socio-demographic data is limited to what is 
available on the patient chart and “Report of a Verified Case of TB” (RVCT)65 form produced by 
the CDC. These data are often based on clinician observations and are mainly focused on 
collecting data on known TB risk factors.  To address the lack of extensive socio-demographic 
data, we designed a survey instrument aimed to ascertain detailed multi-dimensional information 
on the social experience of those with TB. Our hope is that the data generated from this study 
will yield important insights into the modern TB epidemic and facilitate resources being 
efficiently and effectively allocated to those most at risk.    
4.2 Study Design  
 This study is a cross-sectional analysis of current TB patients in Metro Detroit, Michigan. 
The study uses three health departments in the Detroit area: Oakland County Health Department, 
Wayne County Health Department, and Detroit City Health Department. 
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4.2.1 Study Site Recruitment  
 Much of the substantive work of this aim has been in the development of collaborations 
with the state and local health departments and design of a survey instrument to address the 
needs outlined above.  
 We decided to only focus on TB cases occurring in the Detroit Metro given that nearly 
75% of the TB cases occur there.36 In addition, we were particularly interested in understanding 
the social profile of both U.S.-born and foreign-born TB cases. Since many of the U.S.-born TB 
case are identified in the Metro Detroit area this seemed the appropriate geographic area to focus 
on.  
 We recruited three health departments to collaborate with us: Oakland County Health 
Department, Wayne County Health Department, and Detroit City Health Department. Within 
each health department we specifically partnered with the TB control unit. The survey is 
administered by the healthcare workers who routinely oversee directly observed therapy (DOT) 
to identified TB patients in their respective catchment areas.  Information on the survey logistics 
for each site is listed in Table 4.8-1.  
 Our formal collaboration with each health department also included joint IRB approvals 
between the Michigan Department of Health and Human Services (MDHHS), the University of 
Michigan and each individual health department. To do this, we received a sign letter of support 
from each health department.   
4.2.2 Survey Development  
 The process of developing a survey instrument to fit the needs of this specific patient 
population was an iterative process spanning months, and involving many different parties. The 
survey needed to accomplish three main objectives: one) collect detailed socio-demographics 
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variables relevant to the lives of persons with TB in a standardized format; two) collect these 
data in a manner feasible for the patients, study team, and the health department staff to carry-
out; and three) create buy-in from both the state and local health departments to carry out the 
study. 
 In designing the survey instrument, we collated months of information that had been 
gathered from meetings with state and local TB control staff. We also examined the RVCT form 
to identify either components missing from the form, or questions that were based on clinician 
observation, rather than patient self-report. We used this information to identify the key question 
themes that should be addressed with the survey instrument.   
 We used previously validated surveys from major cohort studies to begin compiling 
potential question. These studies included: Jackson Heart Study,116 Detroit Neighbor Health,117 
Multi-Ethnic Study of Atherosclerosis,118 Health and Retirement Study,119 and the Americans’ 
Changing Lives Study.120 However, there were also several major themes for which we could not 
find an adequate question in one of the aforementioned studies. In this case, we designed our 
own questions.   
 The survey instrument was designed to understand the current social profile of TB 
patients in terms of their basic demographics, social status, and economic status. We also wanted 
to gather on evidence on what their social profile was before they were diagnosed with TB. We 
did this explicitly with questions asking them to recall back to before their diagnosis. However, 
we also assumed that current life circumstances can be used as a proxy measure for their social 
experiences before TB. We hypothesized that social factors may have a role in patterning not 
only one’s risk of getting active TB disease, but also the probability that one is exposed to 
Mycobacterium tuberculosis (MTB), the pathogen causing TB disease, as well as the likelihood 
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of transmission of MTB when active TB disease is present. Thus, two main questions guided the 
development of the survey: First, did this population show signs of being in poor health, 
including engaging in poor health behaviors before diagnosis of TB? Second, did individuals in 
this population spend time in locations throughout the community that could have increased their 
likelihood of exposure to and transmission of MTB? The locations individuals frequent as well 
as the quality of their housing or how many people live in a particular house can help us make 
inferences as to where individuals may be exposed to MTB as well as where they may be 
transmitting MTB. In addition, it is plausible that generally being sicker and having worse health 
behaviors could increase the likelihood of progression to active TB once infected with MTB.   
 The final survey was split into three main parts, each containing it’s own battery of 
questions (Table 4.8-1). The final survey included 30-questions and takes approximately 20-25 
minutes to administer.  We piloted tested the survey for several months before survey launch. 
Pilot testing was done among several different populations including: healthcare workers and 
individuals representative of a range of income brackets. Further, before survey launch each 
health department read through the survey, gave feedback, and were presented with the final 
survey instrument before formal launch of the study. There were several changes made during 
the pilot testing process. The original survey instrument was much longer than the final version, 
taking more than 30 minutes to administer. However, based on feedback we shortened the survey 
so that it could be delivered in 20 minutes or less. Additionally, there were several sets of 
questions that seemed to be confusing to certain populations. To address this, we changed the 
language on some questions and pilot tested new language in order to ensure clarity in every 
question.  
 The survey is given at one time point in the course of the approximately 6-9 month drug 
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therapy period of each patient.  When planning for survey administration it was decided, in 
collaboration with the health departments, that surveys should be administered once rapport has 
been built between patient and health care professional—at a minimum of four weeks into 
therapy.   
4.2.3 Grant Support  
 We received funding support from the Rackham Graduate School Research Grant. This 
funding support covered the following items:  
 Printing of 100 surveys to be administered to study participants;  
 A $20 incentive for study participants to improve participation rates. The $20 incentive 
will be in the form of a gift card to a local grocery store such as Meijer;  
 Travel expenses to and from study sites in the Detroit area;  
 Funding in order to cover 3 lunches for each of the study sites in order to provide 
minimal compensation for the healthcare workers administering the survey;  
 Funding to cover the purchase of an external hard drive to ensure secure storage of the 
survey data for subsequent analyses.  
 
4.3 Study Protocols 
4.3.1 Survey Participant Recruitment 
 Healthcare professionals administering DOT invite each patient to participate in the 
study. The healthcare professional explains the purpose of the study as well as any risks 
associated with participation in the study. They then give them the consent form. If the patient 
wishes to participate, they sign 2 copies of the written consent form: one to be left with the 
patient, one to be returned to the health department. In addition, there is a separate HIPPA 
authorization form that allows the healthcare worker to extract information from the patient 
chart.  
 The surveys include a cover page with the patient name and the survey ID #. This page is 
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removed by a representative from the health department. The study team only receives the 
survey with the ID #. The surveys are completely de-identified at the time of receipt by the study 
team.  The health department is the only entity having the linking information; this information is 
not shared with the study team.  
4.3.2 Inclusion/Exclusion Criteria  
 The inclusion criteria for this study are as follows: study participants must be patients 
identified at one of 3 Metro Detroit county health departments: Wayne County, Oakland County, 
and Detroit City Health Department. Any patient currently in treatment or who has completed 
treatment in the last year at one of the participating health departments is eligible to participate in 
study.  
 Additionally, we only invited those patients that can speak and understand English to 
participate in the survey. Those patients unable to speak and understand English were excluded 
from the study.  
 Patients who are under the age of 18 are excluded from the study.  
4.3.3 Informed Consent 
 The healthcare professionals administering DOT present the study, describe its purpose 
and aims, outline risks and benefits associated with participation in the study as well as the 
length of the survey, and invite potential participants to sign the consent forms. Participants are 
invited to sign 2 consent forms: one that covers participation in the survey component of the 
study and one that covers the extraction of patient health information.   
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4.3.4 Confidentiality and Security 
 The study was approved by the Health Sciences and Behavioral Sciences Institutional 
Review Board at the University of Michigan, the Institutional Review Board at the Michigan 
Department of Health and Human Services, and each health department institutional review 
board. Since the Detroit City Health Department is associated with Wayne State University, the 
IRB approval for Detroit City Health Department came through the Wayne State University, 
Institutional Review Board.  
 The cover page of the survey includes the patient name and survey ID#. Only the survey 
ID# is visible on subsequent pages of the survey. The top page of the survey is removed by a 
representative of the health department prior to receipt of the survey by the study team.  
 Individuals are free to withdraw from the survey at any point. If an individual requests to 
have their consent and data revoked, it is allowed. Any data collected will be used in the 
analyses. We will not use any data for individuals who have declined to share their data with us.  
4.4 Results  
 Our primary study objective was to better understand TB patients in Metro Detroit, 
specifically in terms of their social profile. To that end, much of our analyses were focused on a 
thorough description of our study population. We described baseline socio-demographic 
characteristics of the entire population. In addition, we also examined within sample differences 
in key characteristics by nativity. Results will be forthcoming until late 2016. Currently, the 
survey is launched in two health departments and a total of 23 surveys have been administered.  
 The results presented below are preliminary results based on a sample size of 23 with 
65% of the surveys coming from the Wayne County Health Department specifically. We will 
continue to analyze the surveys until the end of the study period in March 2017.  
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4.4.1 Characteristics of the study population  
 Of the 23 individuals included in the analysis, 43% of the sample is U.S-born, 39% 
foreign-born and 18% are missing data on nativity (Table 4.8-2).The sample is 30% 
Black/African American, 26% White, 22% Asian Indian, and 22% some other race. 
Additionally, 26% of the sample identifies as Middle Eastern / North African descent. 65% of 
the sample is female and the mean age is 42.4 years. 
4.4.2 Measures of socioeconomic status  
 In order to ascertain socioeconomic status (SES) we asked questions on the traditional 
measures of education and income as well as other questions regarding sources of income, ability 
to make one’s monthly payments, and health insurance (Table 4.8-2). 17% of the sample had 
some high school education, 30% of the sample reported having a high school (or equivalent) 
education, and 53% reported having some college or above.  48% of the sample reported 
working currently for pay. However, 52% of the sample either refused to answer the income 
question or did not know their income. 17% of the sample reported having an income less than 
$15,000 per year. Further, 43% of the sample reported that making monthly bill payments was 
somewhat difficult, very difficult, or extremely difficult. 96% of the sample had some kind of 
health insurance: 13% of the sample had health insurance through Medicare, 57% through 
Medicaid, and the remaining through some other source such as their employer.   
 In order to augment the data derived from the SES-related questions, we also asked a 
series of questions on housing security, homelessness, and housing quality (Table 4.8-3). 96% of 
the participants reported having a permanent address, 4% of participants did not respond to the 
question. None of the participants reported being homeless in the last 12 months. 91% of 
participants reported sleeping in the sample place every night. 4% of the sample reported living 
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in a public housing project. The average household size for participants was 5.1 persons.  
 Using the income and Medicaid data together, we created an aggregate indicator of SES.  
We used the federal poverty level (FPL) as a baseline measure for incomes that are indicative of 
poverty. The average household size in our study sample was 5.1 (ranging from 2-12 persons). 
The FPL for a family of 5 is $28,410.  We used these data to create cut-points for low SES. If an 
individual reported an income < $30,000 a year or they reported being on Medicaid, they were 
classified as low SES. If they reported an income between $30,000- $75,000 and were not on 
Medicaid, they were classified as mid-SES. Finally, if they reported an income $75,000 or 
greater they were classified as high SES. If respondents were missing data on both income and 
Medicaid, they were classified as SES unknown. Based on this variable, 87% of the sample was 
low SES, 9% mid-SES, and 4% SES unknown.  
 Food security questions were included in order to ascertain individual’s access to healthy 
food as well as their economic ability to address basic food needs. 26% of the sample reported 
making food last until there was money to buy more was somewhat difficult. 70% of the sample 
reported being able to eat fresh fruits and vegetables every day. 9% of the sample reported 
having cut down on the number or size of meals because of money.  
4.4.3 Measures of health-seeking behaviors  
 We also asked a series of questions aimed at understanding health-seeking behavior 
(Table 4.8-3). These questions encompassed both a person’s willingness to seek out care and 
their ability to access healthcare. 87% of patients reported they were either very likely or 
somewhat likely to seek out medical attention for a persistent health symptom.  The reasons they 
would not seek out healthcare included: prohibitive cost, inconvenience in terms of both time 
and distance, and inability to take off work.  
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4.4.4 Measures of subjective social status and social support  
 Participants were asked to report on their view of their social ranking among several 
groups of people as well as their ability to access certain types of social support (Table 4.8-3). 
All but one participant reported feeling about the same rank or above compared to their peers, 
neighbors, and other people in the U.S.  
 We asked a series of four social support questions addressing items related both to 
instrumental support and emotional support.121 The mean level of social support ranged from 3.2 
for the item related to having access to someone who can loan you $100 or less to 3.7 for the 
item related to someone to take you to the doctor.  We also aggregated the four social support 
variables to create a social support summary variable with values ranging from 4-16.  
 While there are many bivariate relationships we would like to explore as we continue to 
collect survey data, we began with examining differences in SES and social support by nativity. 
100% of U.S.-born persons were classified as low SES; foreign-born persons were 67% low 
SES, 22% mid-SES and 4% SES unknown (P=0.4977). Additionally, the U.S.-born reported 
lower levels of social support compared to the foreign-born (P-value = 0.3524). The mean level 
of social support for the foreign-born was 14.00 compared to 12.80 for the U.S.-born.     
4.5 Discussion  
 Both the process of carrying out the study as well as the results offer important insights to 
understanding the socio-demographic profile of TB patients in Metro Detroit. Ultimately, we 
hope the process of ascertaining detailed socio-demographic information on TB patients will be 
replicated in other health departments both in Michigan, and nationally. In addition, we hope our 
findings will be used to guide TB control efforts, particularly in Metro Detroit where limited 
resources need to be allocated efficiently and effectively.  
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4.5.1 Discussion of Study Findings 
 Despite the methodological challenges we faced, we were still able to collect valuable 
information on the social experience of individuals with TB.  Our original study hypothesis was 
that those with TB in Metro Detroit would be among the most vulnerable in society: low SES, 
high levels of instability in housing and food, and low social standing.  Our findings, however, 
are much more nuanced than we anticipated. We found evidence of a working class population 
that is socially stable but with signs of low SES and financial strain. While these data are 
preliminary findings, we believe it is useful and necessary to begin to contextualize these 
findings in what is known in the broader social epidemiologic and TB literature. However, we 
recognize that the profile of TB in Metro Detroit is likely to evolve as we continue data 
collection. 
 17% of our study sample reported having less than a high school education slightly 
higher than the 13.7% of U.S. adults over the age of 25 years and the 10.7% of similar Michigan 
adults.122 Further, 48% of the study sample reported currently working for pay, 13% were retired, 
13% unemployed, and 26% had some other type of employment. The rate of employment in our 
sample was lower that what is reported for both the U.S. and Michigan, 63.9% and 61.5% 
respectively.122 While compared to Michigan and the U.S., these data indicate that the study 
sample did have lower rates of employment and education, a large portion of this population 
was, nevertheless, working and fairly educated. This was contrary to our previous expectation of 
this population being mostly composed of the poorest of the poor. 
 52% of the sample refused to answer the income question; thus, we had to use other 
variables to infer the socio-economic status of individuals. 17% of the sample reported having an 
income less than $15,000 per year. 57% of the sample reported being on Medicaid. We used the 
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U.S. federal poverty level (FPL) to then contextualize both the income and Medicaid findings. 
The FPL is currently set at $11,770 for a household size of 1 and $24,250 for a household size of 
4.123 Based on the respondents that did report their income it is likely that at least 7 households 
are below the FPL (given the average household size of 5.1 in this sample). Further, to be 
eligible for Medicaid in Michigan, an individual has to have an income 133% of the FPL. 
Therefore, based on the Medicaid responses at least 57% of the sample is at or below 133% of 
the FPL.   
 To compare these data to Wayne County as a whole, we used the American Community 
Survey.67 According to the ACS, the median income for Wayne County is $41,421. While the 
ACS does not report the proportions of the population below the FPL, they do report the income 
to poverty level ratio.67 Based on those figures, 25% of the Wayne County population has an 
income to poverty ratio less than 1 –meaning their income is less than the FPL.  Comparatively 
then, our population is likely on the lower end of the income spectrum in Wayne County.  
 The inferences regarding the SES of the study population were further supported by the 
responses to the questions regarding making monthly bill payments. 43% of the study population 
reported that making monthly bill payments was somewhat, very difficult, or extremely difficult. 
While neither the U.S. Census nor the U.S. Federal Reserve ask directly about one’s ability to 
make monthly bill payments, the Federal Reserve does have indicators of financial hardship that 
are nationally representative.  Approximately 33% of the U.S. population reported experiencing 
some level of financial strain with 10% reporting finding it “difficult to get by” in 2014.124 Thus, 
it seems compared to the national standards, our study population was experiencing greater 
financial strain than the average American.  
 This financial strain was also evidenced in the data on food insecurity. 26% of the study 
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sample reported that is somewhat difficult to make food last until there is money to buy more. 
Further, 9% of the study sample reported having to cut down the number and/or size of meals 
because of monetary concerns. While both of these measures signal financial strain, having to cut 
down on the number and/or size of meals due because of monetary concerns also relates to food 
insecurity. In 2014, 14% of U.S. households were food insecure at some point in the preceding 
12 months125 – meaning that at some point in the last 12 months food intakes were reduced or 
eating patterns changed due to financial concerns. Therefore, despite being employed this 
population has significant signs of financial strain as evidenced by both their ability to make 
monthly bill payments and regularly access food.  
 The questions regarding subjective social status and social support lend further detail to 
the social profile of this study population. All but one study participant reported feeling the same 
or above their peers, neighbors, and other people in the U.S.  These data suggest a sense of 
equality—contrary to the sense of isolation we anticipated finding. However, while the social 
support questions taken together indicate a high level of access to social support resources, the 
social support indicator with the lowest mean value was whether you had access to someone to 
loan you $100 or less. 74% of the sample reported having access to this sort of support all the 
time or most of the time. However, 26% of the sample reported having access to this support 
either some of the time or none of the time. This question is indicative of both emotional support 
as well as the perceived ability to draw on one’s social network for tangible aid.126,127 Taken 
together with the aforementioned data on income and financial strain, the variability on this 
question could indicate that this study population feels less able to access a financial safety net 
(or simply does not have a safety net). The reasons underlying this could be a lack of trust that 
anyone in your social network would loan you the $100 if they had it or it could be that there is 
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no one in your social network that has a disposable $100 to loan you. Regardless of the reason, 
these data add further detail to the financial strain experienced by this population.  
 Based on our findings, TB cases in Metro Detroit do not appear to be isolated and 
marginalized. We did, however, find evidence of low SES and financial strain despite this 
population being a seemingly socially stable, working class population.  Moreover, both low SES 
and financial strain could affect several dimensions of TB risk, namely likelihood of progressing 
to active disease once infected with MTB, and to a lesser degree likelihood of exposure to MTB.  
 Low SES could put an individual at risk for TB through several pathways (Figure 4.8-1). 
It could be that being of low SES increases the likelihood of exposure to the MTB pathogen, 
mediated by the neighborhood environment. In their study outlining the pathways by which 
neighborhoods can influence health, Diez Roux and Mair put forward the notion that lower 
individual-level SES is often associated with living in a neighborhood of lower SES.128 Lower 
SES neighborhoods often have lower quality housing, greater exposures to environmental risks, 
and less access to food and health resources.128 From a transmission standpoint, lower housing 
quality evidenced through conditions of over-crowding or lack of ventilation, may increase 
physical contact between a susceptible individual and an infected individual who is actively 
expelling MTB.104 Therefore, the opportunities for transmission to occur are arguably increased 
in neighborhoods of lower SES.  
 We also found evidence of significant financial strain, likely driven by being of a low 
SES. There were three dimensions to financial strain that became evident in these data: not being 
able to make monthly bill payments, not being able to make food last due to financial concerns, 
and not having access to financial safety nets. The combination of these factors could be seen as 
the cumulative effect of financial strain. These factors could affect an individual’s likelihood of 
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progression to active TB disease once exposed to the MTB pathogen. As depicted in Pathway B, 
this pathway could operate through the activation of the stress response and resulting diminished 
immune function. 
  There is a substantial literature on the deleterious effects of stress on many aspects of 
health, including immune function.  While short-term stressors such as those resulting from 
examinations or acute pain can have immediate effects on immune regulation, prolonged stress 
can have both acute and chronic effects on immune function.129 Several studies have explored 
financial hardship as a marker of both acute and chronic psychosocial stress. Steptoe and 
Marmot used an aggregate measure of financial strain comprising difficulty paying bills, being 
able to replace items when needed, and being able to provide the basic needs of the family.130 
They found financial strain was significantly associated with a heightened stress response.130  A 
prolonged stress response results in chronic inflammation leading to a weakened immune state. 
While this may not make an individual more at risk for exposure to TB, it certainly would 
increase the probability of infection once exposed to the MTB pathogen. Related, stress could 
reduce immune function such that the immune system is not able to contain latent TB infections.  
 Studies have documented associations with chronic stress and susceptibility to viral and 
bacterial infections such as cold, influenza, and toxoplasma, and salmonella as well as decreased 
responsiveness to vaccinations.131–134 Cohen et al. reported that those experiencing stressors, 
such as under- or unemployment, lasting more than 1 month had a 2-3 times increased risk of 
contracting rhino-virus induced colds, independent of demographic characteristics or health 
behaviors.135 Aiello et al. found evidence that both ecological stressors such as residential 
segregation and poverty can both influence reactivation of Herpes Simplex Virus, Type 2 (HSV-
2) and Epstein-Barr Virus (EBV) as well as increase risk for acquisition of HIV and progression 
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of HIV to AIDS.133   
 The connection between stress and infectious disease, particularly TB has long been 
studied. The seminal work establishing this link was put forth in 1919 by Ishigami. He was one 
of the first to hypothesis that the association between stress and risk of TB disease was mediated 
by immune function.131,136 In 1953, Wittkower even went so far as to say that a tuberculosis 
patient could better be diagnosed by their psychological characteristics than by chest 
radiography—in particularly indicting stress.131,137 Based on this vast literature, Biondi and 
Zannino posit that experiences of stress are associated with alterations in the host’s 
immunocompetence, particularly cell-mediated immunity (CMI) and therefore should 
themselves be considered causal risk factors of TB disease.131  
 Additionally, experiences of food insecurity likely increase the probability of progression 
to active TB disease once exposed to the MTB pathogen through diminished immune function 
resulting from either the stress pathway or through nutritional deficiencies. If food insecurity 
indicates some level of nutritional deficiency experienced by the individuals as is depicted in 
Pathway C (Figure 4.8-1), then it is plausible that this impacts individual’s immune function. 
 Nutrition, particularly malnutrition is a long and widely known risk factor for TB.138 In 
their famous thesis on the drivers of declines in mortality in England and Wales during the 
1800s, McKeown and Record attributed the rapid decline in TB incidence of this period to 
improvements in the standard of living, especially improvements in nutritional status.139 While 
many have since refuted their claims, there is yet substantial evidence of the relationship 
between nutrition and TB. It is likely that, similarly to that of stress, the association between 
nutrition and TB is mediated through compromises in immune function. Presumably, this is 
driven by compromises in CMI.138,140,141 CMI can keep latent infections in check as well as 
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prevent new infections from occurring upon exposure to MTB.5 Alternatively, the weight loss 
often resulting from MTB infection138,141 can similarly weaken the CMI response increasing the 
likelihood of progression to active TB disease.  
 Moreover, it is also likely that immune function acts as an effect modifier on the pathway 
between exposure to the MTB pathogen and TB disease whereby the probability of transitioning 
from MTB infection to active TB disease is greater for those with a diminished immune function. 
This is presumably driven by changes in CMI in which T-cells are either no longer able to keep a 
latent MTB infection in check or they are not able to mount an adequate response to inhibit a 
primary infection from becoming active disease. As is depicted in Figure 4.8-1, changes in the 
immune function are central to understanding how social factors and one’s social profile may 
augment several dimensions of TB risk.  
4.5.2 Discussion of Survey Administration   
 Throughout survey administration we faced several methodological challenges, namely 
unit and item non-response. We examined reasons for both occurrences in order to mitigate the 
resulting bias as well as to understand how the survey should be modified in future iterations. 
Nationally, unit nonresponse, or unwillingness to participate in the survey, is increasing.142 This 
increase is most notable in cross-sectional surveys in which researchers do not have the benefit 
of offering consistent financial incentives over time.142 Further, unit nonresponse is more likely 
to occur among the disadvantaged: minorities, males, urban residents, singe persons, the poor, 
and those with fewer social ties and attachments143—precisely the population we were most 
interested in studying.   
 Massey and Tourangeau give three primary reasons for non-participation: noncontact—
interviewers being unable to make contact with potential participants; refusals—contact is made 
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but participants decline to participate; and a residual category encompassing such reasons as too 
busy, sick, participant/interviewer differences.142 Refusals consistently account for the largest 
proportion of unit nonresponse—typically 60-65%.144 In our study, noncontact was less of an 
issue given that potential participants were patients enrolled in TB treatment. Refusals were, 
however, the primary reason for nonresponse. Since the interviewer has an established rapport 
with participants prior to the administration of the survey, we were able to gather anecdotal 
evidence for the reasons for nonresponse.  Most of our refusals noted were among foreign-born 
persons who expressed fear of their data being transmitted to the U.S. government.  The 
healthcare workers noted that the rate of nonresponse from foreign-born persons seemed to 
increase in times when contemporary immigration fears and policies were amplified in the 
public.  They also noted this seemed more of an issue with newly arrived immigrants as opposed 
to those with established residency in the U.S. Thus, despite the one-time financial incentive we 
offered survey participants, the risks and threats to confidentiality outweighed the financial 
incentive for this particular population. 
 Item nonresponse, or refusing to answer specific questions, was also a methodological 
challenge we faced. Nationally, rates of item nonresponse are also increasing,145 particularly for 
sensitive questions such as those dealing with income and receipt of government benefits.145 
Meyer, Wallace, and Sullivan hypothesize three reasons for item nonresponse: refusal to answer, 
inability to answer, or failure of the interviewer to accurately record the participant response.145 
Item nonresponse was notable in our study in terms of the income question. Over 64% of 
participants refused to answer this question at all. All three of the above factors certainly 
influenced participants’ willingness to answer the income question in our study. Some 
participants simply refused to answer the question while others cited a fear of disclosure of 
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private information to the U.S. government. Others were simply unable to answer the question 
either because of language difficulties or being a member of a family unit in which he or she is 
not privy to such information.  
 The third explanation for item nonresponse, that of the failure of the interviewer to 
accurately record a response, applies both to the income-related questions in our survey as well 
as to a number of other sensitive questions. In some instances, the response given to a certain 
question was too obscure and time-consuming for the healthcare worker to disentangle and 
indicate on the survey. In these cases, the healthcare workers reported they would skip recording 
a response to the question.  We also saw a related issue in our survey—failure of the interviewer 
to ask the question. In our survey training, we gave our interviewers the autonomy to decide 
whether or not to ask a question based on verbal and nonverbal cues from the participant. The 
healthcare workers indicated that questions of a sensitive nature such as income, housing, and 
social standing sometimes visibly upset the participant. On such occasions, the healthcare worker 
would simply not continue with the question or its related questions. One step we would like to 
implement in future iterations of the survey is the addition of an item on each question indicating 
if the interviewer skipped asking the question altogether. This may help us disentangle refusal to 
answer a question, inability to record a response, and failure to ask a question from one another. 
Regardless, we were often missing data on critical questions such as income. However, we still 
may be able to gain insights on SES based on other related questions. 
 One of the key lessons we learned throughout this process was that it mattered who, 
when, and where the survey was administered. This was particularly true given that we intended 
to survey those who may be vulnerable and/or marginalized in a population.  Foreign-born 
persons would routinely report they believed U.S. government officials, such as immigration 
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workers, would receive the information, and there would be subsequent repercussions. Often the 
willingness of U.S.-born participants to answer questions honestly and to complete the survey in 
its entirety was associated with the level of rapport built between healthcare worker and patient. 
Healthcare workers consistently reported more incomplete surveys and greater general 
discomfort among their patients who were less open and willing to participate in care.   
4.5.3 Strengths & Limitations  
 There are several major strengths to this study that can offer direction to future studies. In 
regards to the study design, ours is one of the first modern studies to utilize a survey instrument 
to collect detailed socio-demographic information on TB patients giving us a more detailed 
understanding of the social profile of those with TB. It is our hope that the data from our survey 
can provide insights into why the TB epidemic has continued in the U.S., and moreover why 
disparities in TB incidence are persistent. Hopefully, studies such as this can call attention to the 
need for tailored TB control strategies that account for the social and economic context in which 
cases arise.    
 Another key strength of our study is that it allows participants to self-report their socio-
demographic characteristics as opposed to the previous reliance on health care worker 
observation on the RVCT form. This is crucial to understanding patterns by race, ethnicity, and 
gender where how an individual identifies him or herself can be much more indicative of their 
social experience than how a healthcare worker may identify them. Further, allowing self-report 
also opens up the opportunity for patients to share more of their story with the healthcare worker. 
This can be key to understanding such issues as housing stability and food insecurity where the 
data gathered on the survey are often indicative of a much larger social trend in the life of the 
individual.  
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 Our study has also developed a framework for collaborations between state/local health 
departments and academia around issues of TB control. Such collaborations are mutually 
beneficial and can result in data that can better inform both TB control and TB research. For 
example, the data collected for the purposes of this study are also being used by each local health 
department to facilitate a better understanding of their patient population. Health departments 
have expressed an interested in being able to tailor their approaches to TB control based on the 
specific needs of their patient population. The data generated from this study, as well future use 
of this survey by the health departments, will allow them to achieve this goal.  
 There are also several limitations to our study. While there are many benefits to the 
survey being administered by healthcare workers (i.e. rapport, trust), some participants were still 
fearful of changes in availability and/or quality of care based on their participation or responses. 
Despite reassurances from the healthcare worker that the survey was in no way linked to their 
care, there were still instances of unit and item nonresponse owing to the survey being delivered 
by healthcare workers.  
 The healthcare workers consistently reported that how questions were interpreted and 
responses given varied based on nativity. For example, several reported questions as to how the 
foreign-born should report their education (i.e. should they report years of education in the U.S. 
vs in their country of origin). Given the high proportion of foreign-born persons in this 
population, it could be beneficial to tailor certain questions to better fit the needs of the foreign-
born population. This may give more accurate responses to such questions.  
 Additionally, utilizing healthcare workers also presented difficulties in survey 
administration. While some healthcare workers were very thorough in their survey 
administration—asking all questions, recording all responses, ensuring the patients charts were 
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filled out, others were less thorough. In the future, we would like to employ a more extensive 
survey training and follow-up visits, including having each healthcare worker pilot the survey 
and receive feedback individually. We did address these issues in subsequent meetings with the 
health department staff, however, this would be better addressed during survey training.  
 Surveys are notoriously vulnerable to recall bias and our survey was no different. This 
was particularly concerning for the series of questions in which participants were told to recall 
the time before they had TB. For some participants, this may have been up to one year ago. 
Moreover, we suspect that participants may have remembered their time before TB as better than 
it was in comparison to their current status. Thus, questions such as self-rated health before TB 
are likely not a true representation of the individuals’ status before TB.   
 Finally, since this was a descriptive study, we did not have a control group without TB. 
We could not compare our study results with a TB-free population, which would have allowed us 
to quantify the degree to which certain variables put those with TB at increased risk. However, 
we believe having the baseline socio-demographic characteristics of this population will make 
such studies possible in the future.  
4.6 Next Steps  
Data collection will continue until August 2016. We expect to have approximately 70 
participants total from all three health departments.  Our original study aim was to describe the 
social profile of the Metro Detroit TB population. However, we found that even within this 
population there was significant heterogeneity between health departments. Future analyses will 
focus on describing the study results separately for each health department.  
 Moreover, the participating health departments have expressed the need for this type of 
survey instrument in other TB control units as well as other infectious disease units. Eventually, 
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we aim to publish the study methodology and survey instrument in the hopes that it can be used 
on a national scale. 
From an epidemiologic perspective, this study sets the stage for additional studies of the 
social experience of TB patients. The data from this study can highlight which variables are most 
relevant to understanding the social profile of the population with TB, helping to inform how 
future studies are constructed. For example, a follow-up study could employ a population-based 
case-control design in which TB cases in a particular area are matched with controls selected 
from the TB-free base population.  By doing so, we could better understand how the population 
with TB compares to the TB-free base population.  
4.7 Conclusions  
 Our study is one of the first to gather detailed data on the modern-day social profile of 
individuals with TB.  Our findings suggest that despite evidence of stability on several social 
markers, the modern-day social profile of those with TB is one of low SES and significant 
experiences of financial strain. Perhaps what is most striking about our findings is that despite 
this being an employed population and not of significantly lower education, there is still 
evidence of this population not being able to meet basic financial needs. This implies that at-risk 
populations for TB should not simply be defined by traditional TB risk factors (i.e. 
homelessness, drug-use, stay in a correctional facility). Rather, our study findings suggest that at-
risk populations need to include those for whom financial insecurity and strain are persistent 
issues. Tailoring TB control strategies to include such populations may be able to both decrease 
TB incidence overall and decrease persistent disparities. 
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4.8 Tables & Figures 
Table 4.8-1 Study Sites  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health 
Department 
Survey Start Date Survey End Date 
Current # of 
Surveys 
Oakland County  9.8.15  5 
Wayne County  7.23.15  15 
Detroit City  3.1.16  3 
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Table 4.8-1 Major components of the survey instrument.  
 
 
Survey Section Specific Variables 
Part 1: Demographics 
Race 
Gender 
Martial Status 
Education 
Part 2: Life Before TB 
Self-rated health 
Alcohol usage, past and current smoking 
behavior, physical activity 
Healthcare-seeking behaviors, barriers to 
seeking healthcare 
Locations frequented throughout the 
community 
Part 3: Current Status 
Housing (history of homelessness, transience 
in housing, crowded housing condition)  
Neighborhood condition  
Health insurance, barriers to having health 
insurance  
Employment 
Income (including ability to make monthly bill 
payments 
Subjective social status  
Access to social support  
Food security  
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Table 4.8-2 Demographic characteristics of the study sample 
N = 23           
Mean Age (years) 42.4 
      
   
  
# % 
   
# %  # % 
Origin 
    
Self-Rated Health Before TB   Education  
 U.S.-born  10 43 
 
Excellent  10 43 Some high school 4 17 
Foreign-born  9 39 
 
Good  
 
11 48 High school / GED 7 30 
Missing  
 
4 18 
 
Fair  
 
2 9 Some college 5 22 
        
 Bachelor/Associate’s 
Degree 
5 22 
Race/Ethnicity  
   
Alcohol Use Before TB  
 
Advanced Degree 1 4 
Black/African American  7 30 
 
Yes 
 
8 34 Other professional degree 1 4 
White  
 
6 26 
 
No  
 
15 65   
 Asian Indian  5 22 
     
  
Other  
 
5 22 
 
Smoking Before TB  
 
   
 
     
Yes  
 
7 30   
 Middle Eastern/North African  6 26 
 
No 
 
15 65   
     
Missing  
 
1 4   
 Gender  
    
Ever Smokers  
 
   
 Male  
 
8 35 
 
Yes  
 
5 22   
 Female  
 
15 65 
 
No  
 
13 57   
 
    
 
Missing  
 
5 22   
 Marital Status  
       
  
Married  
 
10 43 
 
Physical Activity  
 
   
 Separated  1 4 
 
Never  
 
5 22    
Divorced  
 
2 9 
 
< 1 x per week  2 9   
 Widowed  3 13 
 
Once a week  7 30   
Living with a partner   2 9 
 
Multiple times per week 3 13    
Single   5 22  Almost every day  6 26    
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Table 4.8-3 Participant response to selected questions  
  
# %  
         Total Surveys  23 100 
         Health-Seeking Behaviors  
          
Suppose you had a health symptom that had been bugging you for a couple of weeks, how likely would you be to seek out medical 
attention?  
Very Likely (1)  15 65 
         Somewhat Likely (2)  5 22 
         Somewhat Unlikely (3)  2 9 
         Unlikely (4)  1 4 
                      What are the biggest reasons you wouldn't seek out medical attention?  
Cost  
 
1 4 
         Too Far Away  1 4 
         Can't Take Off Work  1 4 
         Time/Inconvenience 2 9 
         Lack of health insurance 4 17          
Other  
 
11 48 
         Refused/Didn't Ask  3 13 
         
             Health Insurance  
           Some kind of health 
insurance  22 96 
         Medicaid  13 57 
         Medicare   3 13 
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Table 4.8-3 Continued. 
Income  
 
# %  
Source of Income  
  
 
Working now for pay  11 48  
Unemployed/Looking for work 2 9  
Retired  
 
3 13  
Homemaker  3 13  
Not working  1 4  
Unpaid Family Worker  1 4  
Student 2 8  
    
 
How difficulty is it to make monthly payments?   
Not difficult at all  11 48  
Somewhat difficult  8 35  
Very difficult  1 4  
Extremely difficult 1 4  
Missing  
 
2 8  
    
 
Total Yearly Income ($) 
  
 
< 15,000  
 
4 17  
15,000 – 30,000  3 13  
30,000 - 75,000  3 13  
> 75,000 1 4  
Do not know  4 17  
Refused  
 
8 35  
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Table 4.8-3 Continued. 
Social Ranking  
  
 
Thinking about your life, how would you say you rank among the following groups of people:   
 
Below  
# (%) 
Same 
# (%) 
Above  
# (%) 
Missing  
# (%) 
Your peers  1 (4) 19 (83) 1 (4) 2 (8) 
Your neighbors  1 (4) 16 (70) 3 (13) 3 (12) 
Other people in the U.S.  1 (4) 19 (83) 1 (4) 2 (8) 
*Below (1); Same (2); Above (3)  
 
 
    
 
Types of Social Support  
 
Means (SD)  
Someone to confide in / talk to about your problems  3.33 (0.86)  
Someone to take you to the doctor  3.43 (0.84)  
Someone to help with daily chores if you were sick  3.65 (0.57)  
Someone to loan you $100 or less  3.22 (1.04)  
*All the time (4); Most of the time (3); Some of the time (2); None of the time (1); Don't know (1)   
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Table 4.8-3 Continued. 
 
 
Food Security  # % 
    How difficult is it for you to make your food last until you have money to buy 
more?  
Not difficult at all  
 
17 74 
    Somewhat difficult   6 26     
Very difficult  0 0     
Extremely difficult  0 0     
  
       How often are you able to eat fresh fruits and 
vegetables?  
   Everyday  
 
16 70 
    A few times per week  5 22 
    Less than once per week  2 9 
    Never        
        Have you had to cut down the number or size of meals because of 
money?  
 Yes  
 
2 9 
    No  
 
21 91 
    How often have you had to do 
this?  
     A few times per week  1 4 
    Less than once per week  1 4 
    Never or NA  3 13 
    Missing  18 78     
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Figure 4.8-1 Conceptual framework depicting how low SES and financial strain may affect TB risk.  
Low SES  
Stress 
Response 
Exposure to 
MTB 
Active TB 
Disease 
Transmission 
of MTB 
Diminished 
immune 
function  
Neighborhood 
environment   
Financial strain  
Ability to pay 
one’s bills  
Food 
insecurity 
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CHAPTER 5. CONCLUSIONS 
5.1 Review of major findings  
 This dissertation sought to use to use an innovative approach, integrating traditional 
molecular epidemiologic methods with spatial data and a novel socio-demographic survey to 
understand patterns of TB incidence in Michigan, and the drivers of persistent disparities in TB 
incidence. My goal is that the results of this dissertation will have direct implications for 
statewide and national TB control.  In particular, I hope that the results of this dissertation will 
help us better understand the social patterning of infectious disease in the U.S. so that we might 
design interventions that can both reduce disparities and prevent disparities in infectious diseases 
from developing in the future.  
 This dissertation was composed of three studies. The first study analyzed trends in TB 
incidence for the state of Michigan from 2004 through 2012. The results of this study 
demonstrated that while the incidence of TB resulting from both recent transmission and 
reactivation latent TB infection (LTBI) is decreasing in Michigan, significant disparities are 
evident, particularly along lines of race and nativity (Chapter 2). The second study looked within 
the population of TB cases for predictors of recent TB transmission, using genotypic clustering 
as a proxy for cases resulting from recent transmission. The findings of this study suggest that 
the predictors of recent transmission are critically different for U.S.-born and foreign-born 
populations. For U.S.-born populations, the composition of the neighborhood environment, 
including density and neighborhood-level disadvantage, is a better predictor of recent 
transmission compared to traditional TB risk factors and/or clinical factors (Chapter 3). The third 
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and final study used the data collected from the preceding two studies, as well as anecdotal 
evidence collected from local public health departments, to pilot test a novel survey instrument 
aimed at ascertaining detailed data on the social profile of TB patients in Metro Detroit. This 
study found that while traditional markers of social vulnerability such as extreme poverty and 
homelessness may not be as evident in this population, there is evidence of persistent financial 
hardship and strain likely resulting in an increased risk for primary infection with 
Mycobacterium tuberculosis (MTB) as well as increased risk for progression from infection to 
active disease (Chapter 4).  
5.1.1 Trends in TB Incidence in Michigan, 2004-2012 (Chapter 2) 
 In the first study of this dissertation, we examined trends in TB incidence both overall for 
the state of Michigan as well as among subgroups by race, nativity, sex, and age and did so 
separately for those cases resulting from recent transmission and reactivation of LTBI.  TB 
incidence overall showed a decline from 2004-2012, declining from 2.69 cases per 100,000 
persons in 2004 to 1.28 cases per 100,000 in 2012. We then examined whether these decline 
rates were significantly different for subgroups of race, nativity, sex, and age. Upon finding 
evidence that the decline rates were not different, we then proceeded to use multivariable models 
to compare the average incidence rate for each subgroup of the population. We found that among 
those cases resulting from recent transmission, the greatest disparities were observed by race—
Blacks had an incidence rate 19 times greater than that of Whites when controlling for age, sex, 
and nativity. Among the cases resulting from reactivation of LTBI, the greatest disparities were 
observed by nativity—the foreign-born had an incidence rate 19 times greater than the U.S.-born 
when controlling for race, sex, and age.  
 Disparities in TB incidence in the U.S., particularly by race and nativity, are not a new 
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finding in TB research and control. For decades we have known that the foreign-born have a 
higher incidence rate of TB than the U.S.-born and that Blacks, Asians, and Hispanics have 
much higher rates of TB than Whites.34 However, what this study offers is a more nuanced 
understanding of these disparities. Rather than reporting these disparities in a univariate model, 
as has often been done in the past, we used multivariable models to understand how the effects of 
each variable differ when examined together. Multivariable approaches are not often used, 
however, the few studies that do employ multivariable approaches also report that the inferences 
of their findings change substantially between univariate and multivariable approaches.84 Both 
the magnitude of the disparities we found, as well as the degree of the suppression effect of 
nativity on race, are significant findings our study offers to the wider TB literature.  
 One of the ancillary goals of this study was to be able to begin to understand how social 
factors, such as race and nativity, may be driving disparities in TB incidence in Michigan. While 
we were constrained by the available data we could utilize in the study, it is a first step in 
understanding the pattern of TB incidence in Michigan. Follow-up work should seek to 
understand what race and nativity are proxies for in this population.  Is it simply that the TB 
incidence in the foreign-born is driven by the baseline prevalence of TB in their country of 
origin? Or is there something particular about the social experience of foreign-born individuals 
once in the U.S. that puts them at greater risk for TB incidence? Moreover, what is race a proxy 
for in this population? Why do we see a greater incidence rate of transmitted TB among Blacks? 
These sorts of questions need to be examined from a social epidemiologic framework in order to 
move such studies from simply delineation of disparities to understanding mechanisms driving 
disparities so that we may intervene in the future.  
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5.1.2 Drivers of TB Transmission in Michigan (Chapter 3)  
 In the second study, we compiled the population of TB cases collected in Michigan from 
2004-2012 and looked within the sample to understand drivers of recent transmission. As has 
been shown in previous studies, the drivers of transmission are notably different for U.S.-born 
and foreign-born populations46,92,100 such that a stratified analysis is necessary to accurately 
understand the risk factors in each population.  For the foreign-born population, there were only 
two significant predictors of recent transmission: race and being a known contact of an infectious 
case of TB. Among the foreign-born, Asians had an increased prevalence of recent transmission 
compared to Whites, after controlling for measures of the neighborhood environment, and other 
social risk factors. That being said, more work is needed to understand how the Asian population 
as a whole differs from other foreign-born populations. It may be that Asian immigrants are more 
likely to live in closer proximity to one another, or in multi-family households. Future studies 
could ask questions related to housing and crowding to better understand the origins of this 
disparity. Additionally, future studies would benefit from disaggregating the Asian racial group 
into the ethnically diverse groups that compose it. This may facilitate a better understanding of 
what is driving recent transmission in this population.  
 Among the U.S.-born, the most significant predictors of recent transmission were 
observed at the neighborhood-level. Both neighborhood-level density and neighborhood-level 
disadvantage were associated with a significantly higher prevalence of transmission, even after 
controlling for individual-level covariates such as race, sex, and age.  Building on the previous 
study, these results help us begin to understand the racial disparities in TB incidence, particularly 
among the U.S.-born. Among U.S.-born populations, race is likely a proxy for neighborhood-
level disadvantage such that when neighborhood-level factors are included in a model with 
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individual-level race, individual-level race is no longer a significant predictor of transmission.  
 Both the fields of social epidemiology and infectious disease epidemiology acknowledge 
the importance of place in determining risk of disease. For infectious disease, the importance of 
place is usually due to the creation of spaces for individuals to interact with a particular 
pathogen—be it the transmission of, or exposure to the pathogen.107,146 For social epidemiology, 
the neighborhood can represent aspects of the structural barriers influencing individuals’ ability 
to have and maintain health.128,147 In this study, we found evidence that both aspects of the 
neighborhood environment matter for differentiating recent transmission from reactivation of 
LTBI.  There are many within the field of TB research, particularly in low burden countries such 
as the U.S that have called for targeted TB resource allocation for high risk groups. Our findings 
suggest that the definition of high risk may need to incorporate markers of the neighborhood 
environment rather than only individual-level factors.  
5.1.3 TB in Metro Detroit (Chapter 4)  
 In many ways, the third study is a natural response to the findings of the first two. The 
first two studies point to the ways in which TB incidence and transmission may be socially 
patterned. However, in both of those studies our ability to make inferences regarding the 
mechanisms underlying the social drivers was impeded by the data available. The third study of 
this dissertation attempted to address this gap by pilot testing a survey instrument that could 
collect much more detailed socio-demographic data on TB cases—specifically those identified in 
the Detroit Metro area.  
 We expected to find evidence that this population of individuals was of extremely low 
socioeconomic status (SES), socially marginalized, and vulnerable such that they would not have 
consistent income, housing, and food.  However, the picture that is becoming clear as the surveys 
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continue to be analyzed is much more nuanced than we anticipated. We did not find evidence of 
extremely low SES; in fact, many of the participants had greater than a high school education, 
and nearly all of them were currently working.  Despite this, however, a large proportion of this 
population was on Medicaid, had difficulty making their monthly bill payments, with some even 
showing signs of food insecurity. The persistent financial hardship and strain experienced by 
these individuals can cause significant stress, resulting in immune dysfunction and making 
individuals more likely to progress to active TB disease once infected with the MTB pathogen. 
Additionally, in light of the findings from the previous study (chapter 3) regarding the 
neighborhood environment, it may be that the evidence we found regarding the financial strain of 
individuals may also be indicative of a lack of upward mobility in terms of their social standing, 
and their ability to move from their neighborhoods. Thus, their financial strain may also be an 
indicator of residing in neighborhoods where one is more likely to be exposed to the MTB 
pathogen, and lacking the resources to move from such an environment. Future iterations of this 
survey instrument should collect patient address information so that neighborhood level factors 
could be linked with each survey response.  
5.1.4 Working with local public health agencies 
 Developing collaborations with local health departments has proved a most fruitful and 
beneficial endeavor. In fact, much of the learning for this aim came from the relationships 
developed with each health department. During meetings with the health departments, TB 
control staff shared stories and observations from their patient populations, as well as what they 
perceived to be the biggest needs of these populations. Many of the TB control staff had been 
administering directly observed therapy (DOT) to TB patients for many years, and had seen how 
the TB epidemic had changed and evolved over time. The TB control staff takes time to learn 
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about each of their patients—adapting the location and timing of the drug therapy to be the most 
unobtrusive to each patient, thereby ensuring a high probability of treatment completion. It 
became clear the TB control staff knew much more detail about the patient’s life than is collected 
or accounted for in the TB surveillance data. When we approached each of the health 
departments with the idea of a collaborative study, we did so from the perspective that the 
information we would collect on the survey was simply a standardized way to capture the wealth 
of anecdotal evidence they were already gathering on their own.  
 It is our hope that the survey instrument will continue to be used in the health 
departments as a tool to better understand patient populations and tailor resources accordingly. 
We also hope that this tool can be tailored for use by other infectious disease control teams. 
While the U.S. has done substantial work in reducing the burden of infectious diseases 
nationally, disparities across a range of diseases continue to persist and in many cases widen.59 
Better understanding how the social environment may pattern such disparities can give us tools 
to address these disparities currently, but may also give us the knowledge to prevent such 
disparities from developing in the future. As new infectious diseases continue to emerge, and 
current infectious disease continue to evolve, the U.S. will have to adapt the strategies by which 
we address such diseases, both to prevent outbreaks as well as prevent disparities in infectious 
disease incidence from becoming entrenched. We our hope our survey instrument will be one 
such strategy for U.S. infectious disease control. 
5.2 Bringing it all together  
 The three studies of this dissertation are best understood as building upon one another.  
As I reflect on this dissertation, and the inferences and conclusions that can be drawn from it, 
several themes emerge: one, the importance of incorporating historical evidence into our work, 
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two, critically thinking about how we study race in epidemiology, and three moving towards a 
consequential epidemiology.   
5.2.1 Incorporating History  
 Much of what I found in this dissertation is aligned with what we have known for 
decades about TB: that it targets society’s most vulnerable, and is patterned along lines of social 
disadvantage.86  My dissertation, in many ways, is then a remembrance of history and an 
incorporation of that into our current understanding of TB and the methodologies by which we 
address TB in the U.S. context.   
 Routine reporting of TB began around 1953 and from 1953-1985 the incidence of TB 
declined by nearly 82%.32 Much of this decline is credited to the development of drug therapies, 
such as Streptomycin in 1944, that could target TB specifically and effectively.148 Even after the 
resurgence of TB in the 1980s and 1990s, the advent of routine genotyping allowed those in TB 
control to use individual-level factors to halt population-level spread of the disease. These 
technologies have been enormously successful in reducing the incidence of TB in the U.S. 
However, one unintended consequence of these advances has been the failure to remember the 
historical knowledge of the ways in which TB responds to population-level changes.  
 The advances in TB control have been successful in reducing the incidence of TB, but 
these reductions are not experienced uniformly across the population. The successes in control of 
TB have been felt more by advantaged populations, creating a situation in which disparities in 
TB incidence can and do persist. Similar to what was reported in the 19th and early-20th 
centuries, TB remains disproportionately burdened among racial/ethnic minorities and 
immigrants.31 History tells us that these disadvantaged populations are often created in the wake 
of population-level shifts: influx of immigrants, movements into and out of urban areas, re-
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organizations of social structures. Thus, in conjunction with individual-level factors, our 
contemporary methods for TB control need to account for current and future population-level 
shifts that will likely result in new high-risk groups, or the perpetuation of the current 
stratification of the population.  
5.2.2 Incorporating race into infectious disease epidemiology  
We continue to see racial disparities in TB in the U.S.,55,59 which has led some in the field 
to imply that these disparities can be attributed to the biological differences due to race. Much of 
this argument relies on flawed research104 indicating that Blacks have a genetic susceptibility 
both to acquiring TB infection80,149 and to developing active TB disease.150 Given the decades of 
research showing there is greater heterogeneity within a particular racial group than across racial 
groups,151  it is unlikely that genetic differences are able to account for the disparities observed in 
the susceptibility, acquisition, and progression of TB.152 More likely, group level differences in 
susceptibility to TB infection or disease are linked to an individual’s geographic origins.104,152  
Although it is well accepted that race is a social construct, 153 difficulties arise in how 
best to operationally incorporate this knowledge into research. While many public health 
researchers regularly incorporate race into their statistical models and document racial patterns in 
their findings, this is often where the discussion ends. However, a larger issues remains: If race is 
a social construct, then only describing racial patterns in health, without any hypothesis or 
framework explaining what race is a proxy for in a given context, may serve to perpetuate the 
biologizing of race.   
        While social epidemiology has been leading the charge in incorporating a critical 
understanding of race into epidemiologic investigations, research focusing on structural 
determinants and “fundamental causes”154 may leave many of those outside the field of social 
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epidemiology feeling paralyzed by the implications of such notions. That is, short of structural 
change, there is not likely to be reductions in the persistent disparities many of us are 
documenting. However, authors such as Acevedo-Garcia, argue that there are likely to be 
intermediaries in the long chain of events from structural influences to health—intermediaries 
that may be critical points for intervention.155 Despite the complex pathways linking structural 
determinants to individual health outcomes, social epidemiology can lead the field by examining 
race in a way that illuminates the meditators on the pathway between social constructions of race 
and health with the goal of reducing racial disparities. For example, in chapter 3 of this 
dissertation we found that among the U.S.-born population, the association between race and 
recent transmission was null when neighborhood disadvantage was included in the statistical 
model. Rather than simply reporting racial disparities in recent transmission, this finding helps 
illuminate what may be driving the racial disparity in this context—the neighborhood 
environment.  This gives those in TB control, at the state and local level, the necessary data to 
better tailor resources to high-risk neighborhoods.    
5.2.3 Towards a consequential epidemiology  
 One question continually comes up as I bring together all three studies: how do the 
findings of this dissertation move us closer to the goal of eliminating TB in the U.S.? In 2013, 
Galea proposed a new approach to epidemiology known as “consequential epidemiology”.156 In 
making the case for this new approach he argues that, “academic epidemiology now spends most 
of its time concerned with identifying the causes and distributions of disease in human 
populations and far less of its time and imagination asking how we might improve population 
health.”156 He uses the foundational definition of epidemiology as part of a two-pronged mission 
that is aimed at understanding the distribution of disease and its determinants so that we may 
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intervene to improve population health157 as the base for his charge.  
 In my dissertation, the first two studies are focused explicitly on understanding the 
distribution of TB, and specifically its social determinants. However, the third study is my 
attempt to bridge the gap between the academic study of TB and the public health practice of TB 
control (and perhaps other diseases). The first two studies are needed to understand and quantify 
contemporary disparities in TB and their drivers. While they have utility in their own right, they 
also provide the foundation for the third study. Designing a survey instrument using the tools of 
social epidemiology and survey research can certainly improve our understanding of the social 
characteristics of TB. Practically, however, it is my hope that the survey instrument will be used 
to inform TB control practices at the state- and local-levels. Such a tool can incorporate the 
knowledge we have of persistent disparities in TB into a mechanism to address and ameliorate 
these disparities. 
5.3 Moving Forward  
5.3.1 U.S. TB control  
 In 2014, there were 9.6 million new cases of TB and1.5 million deaths due to TB 
globally.2 The World Health Organization (WHO) recently released their new goals to accelerate 
global progress towards ending TB.2 Explicit in these goals is a framework for helping low 
incidence countries achieve TB elimination.  The WHO classifies low incidence countries as 
those having less than 100 TB cases per one million population.158 The goal is that low incidence 
countries achieve pre-elimination status (defined as < 10 TB cases per one million) by 2035 and 
elimination (defined as < 1 TB case per one million population) by 2050.158 To that end, the 
WHO has outlined 8 priority actions that low-incidence countries should take in order to reach 
pre-elimination status:   
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 Ensure political commitment, funding, and stewardship for planning and essential 
services of high quality;  
 Address the most vulnerable and hard-to-reach groups;  
 Address special needs of migrants and cross-border issues;  
 Undertake screening for active TB and latent TB infection in TB contacts and selected 
high-risk groups, and provide appropriate treatment;  
 Optimize the prevention and care of drug-resistant TB;  
 Ensure continued surveillance, program monitoring and evaluation, and case-based data 
management;  
 Invest in research and new tools;  
 Support global TB prevention, care, and control.158,159  
 The U.S. is among the 30 low-incidence countries targeted by the WHO for achievable 
elimination of TB in the near future. With the goal of eliminating TB in mind, the challenge for 
U.S. TB control is to consider how to implement the action items set forth by the WHO that will 
put us on a trajectory for elimination.  
 With declining incidence and obvious successes in TB control over the last century, it 
seems that TB elimination is, in fact, an achievable goal. However, elimination of TB in the U.S. 
faces two key obstacles: one) diminished funding at the federal, state, and local levels, and two) 
the existence of silent epidemics in geographically and demographically defined groups.104  
 In 2008 the Comprehensive Tuberculosis Elimination Act of 2008 was passed by 
Congress explicitly outlining funding to be allocated towards both TB research and TB control 
programs with an increased focus on high-risk groups, including the foreign-born.160 The result 
of the legislation was increased funding to the Centers for Disease Control and Prevention 
(CDC) and the National Institutes of Health (NIH) to carry out the aims of the legislation. 
However, in the years following the passage of the law, the federal budget to both agencies was 
severely cut, limiting their ability to address the aims of the law.161 In 2014, the legislation was 
re-introduced and is currently held up in sub-committee hearings in Congress. This legislation 
prioritizes funding to state governments, proposing to focus on high-risk groups such as the 
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foreign-born, uninsured, and homeless.162 Importantly, it also has provisions to award special 
funding to state and local governments as well as to federally qualified health centers.162 
 This new legislation could address both challenges outlined above for TB elimination in 
the U.S. as it would renew political will and subsequent funding for TB activities. Not only does 
this give those in TB control the resources to carry out their activities, but it also incentivizes 
new initiatives to address high-risk populations. In addition, the special provision in the proposed 
legislation to include federally qualified health centers in funding awards is a particularly critical 
component of addressing persistent disparities in TB incidence, particularly among the U.S.-
born. Federally qualified health centers were one of the community-based interventions provided 
for under the Affordable Care Act (ACA) to increase access to healthcare in disadvantaged 
communities—particularly minority communities and communities of low SES.163,164 These 
disadvantaged communities are oftentimes politically and socially marginalized and thus, the 
weight of TB, among other diseases, often goes unnoticed and therefore, unaddressed in these 
populations.  Implementing active TB case finding, and subsequent treatment, using the existing 
infrastructure of the federally qualified health centers may be a practical way to target TB control 
in a resource constrained environment. 
5.4 Future research  
 This dissertation has set the stage for follow-up action in the fields of TB research and 
public health practice. One action that could benefit a range of infectious diseases is the 
collection of more comprehensive surveillance data. There are a number of infectious diseases in 
the U.S that are classified as notifiable diseases of which reporting is mandatory. Using this 
existing infrastructure as a mechanism to collect more detailed socio-demographic information, 
may facilitate a better understanding of high-risk groups for particular diseases. This could also 
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lead to a better understanding of enduring disparities in TB research. Future TB studies should 
aim to understand the mechanisms driving disparities in TB incidence and how those drivers may 
be different for U.S.-born and foreign-born populations. This dissertation is a necessary first step 
in documenting these disparities and highlighting potential mechanisms. Follow-up studies 
should employ more detailed socio-demographic data to understand the underlying systems, 
particularly structural influences, giving rise to such disparities.  
 Infectious disease research may also benefit from research that encompassing more than 
one infectious disease. This could be beneficial from both the social and biological viewpoints, 
as there is likely substantial overlap between high-risk groups among multiple infectious 
diseases. Understanding the social conditions that puts one at risk for multiple infectious disease 
could lead to more efficient and effective allocation of resources. In chapter 3 of this dissertation 
we found that for U.S.-born individuals, the neighborhood environment played a significant role 
in predicting whether an individual was a recently transmitted case of TB. However, the role the 
neighborhood environment plays in augmenting risk of MTB infection and TB disease is likely 
not limited to TB. These findings could be applied to a range of infectious diseases. Thus, in 
increasingly resource-constrained environments for research and public health practice, we, as a 
field, could benefit from studies that examine more than one outcome.  
 The shift to examining more than one infectious disease in a given study could also be 
beneficial for understanding the biological processes at work throughout the tenure of an 
infection/disease. Borrowing from the multimorbidity model165 as well as the increasing number 
of studies examining pathogen burden,166 we could also begin to examine the consequences of 
multiple co-occurring infectious diseases. There is a substantial literature developing 
investigating the effects of multiple infections on the pre-mature aging of the immune system.167–
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169 While these studies mostly focus on sub-clinical infections that reactivate over the life course, 
it is reasonable to assume that the burden of multiple infectious diseases with clinical endpoints, 
such as TB, measles, pertussis, etc. may also have consequences for the aging of the immune 
system over the life course.  The shift to examining more than one infectious disease in a given 
study could also be beneficial for understanding the biological processes at work throughout the 
tenure of an infection/disease. Borrowing from the multimorbidity model165 as well as the 
increasing number of studies examining pathogen burden,166 we could also begin to examine the 
consequences of multiple co-occurring infectious diseases. There is a substantial literature 
developing investigating the effects of multiple infections on the pre-mature aging of the 
immune system.167–169 While these studies mostly focus on sub-clinical infections that reactivate 
over the life course, it is reasonable to assume that the burden of multiple infectious diseases 
with clinical endpoints, such as TB, measles, pertussis, etc. may also have consequences for the 
aging of the immune system over the life course.  
 Finally, the pilot study we carried out in Metro Detroit provides an excellent foundation 
for future studies both in TB and other related infectious diseases. It is proof of concept that such 
a study can be carried out, and that valuable data can be derived from it. Follow-up studies 
should focus on developing a control group for comparison. Our study was a pilot study and 
therefore did not have a population with which to make comparisons. Future studies that are able 
to quantify the differences that exist between the TB population and the TB-free population will 
provide better evidence for how TB control teams can more effectively address the needs of their 
patient populations.  
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5.5 Conclusion  
 Despite enormous successes in TB control over the course of the 20th century, TB 
continues to disproportionately affect the poor, racial/ethnic minorities, and urban dwellers.  This 
dissertation has shown that significant disparities in TB incidence are persistent despite 
organized TB control efforts. Moreover, this dissertation has consistently demonstrated that the 
social and economic context of individuals is a critical factor in determining risk of TB as well as 
perpetuating disparities in TB.  The social survey we piloted in Metro Detroit will lead to 
invaluable insights into the contemporary social profile of individuals with TB. Results from this 
dissertation research should have direct implications for statewide and national TB interventions.
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APPENDIX A Social Survey  
Tuberculosis in Michigan: Survey on socio-demographic factors among TB patients 
 
 
The following information needs to be filled out by a representative of the health department:   
 
 
Patient Name   
 
 
Date of Birth:   
 
 
Survey ID #:  
 
 
Survey 
administrator:  
 
 
 
Treatment start date  
  
INSTRUCTIONS: 
 
Only those 18 years of age and older who can speak and understand English should be invited to 
participate. Do not offer the survey to persons not fitting those criteria. 
The survey administrator should fill out the top portion of this page which will be used only by 
the health department. The patient name that corresponds to a given survey ID # will NOT be 
seen or used by the University of Michigan. The survey ID # is a 4 digit number located in the 
top right corner of every page.  
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Upon completion of this survey, the top page will be torn off and retained by the health 
department.  
Once the above information has been filled in please proceed to the following page and read the 
introduction inviting the patient to participate in the survey. At the end of the survey there are 
questions to be filled out based on the patient chart. This information need not be obtained from 
the respondent.  If a respondent chooses not to participate in the survey, this information should 
NOT be filled in.  
At any point once the survey has started, a respondent may opt out of finishing the survey and 
receive full compensation for their time. If this happens, please thank them for their time and 
give them the incentive.   
If at any point during the survey a participant seems upset by the questions, the interviewer may 
stop the survey. In this case, the participant would receive full compensation.  
If the survey needs to be done on 2 separate occasions, please note down the date/time for the 
start and finish time of the survey.  
Unless otherwise noted, all answer choices should be read aloud to the survey participants. 
Several questions indicate that you should allow the survey respondent to volunteer information. 
In this instance, the answer choices do not need to be read aloud.  
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SAY: To help us better understand how tuberculosis spreads in Michigan, we are asking you to take part 
in a short survey administered through the University of Michigan. The survey will take about 20 
minutes and your participation is completely optional. Information obtained in the survey will be used 
to inform the care given to future TB patients by the public health department. All information will be 
kept confidential and will not be traceable to you except through the health department. The 
information used by the University of Michigan will not include any identifying information that can be 
linked back to you. We are offering a $20 gift card for participation. At any point in the survey you may 
refuse to answer a question or stop the survey altogether and you will still receive the gift card.  
 
 Are you willing to participate in the survey? 
□ NoThank subject for their time and stop interview.  
□ Yes  Give respondent the consent form and HIPPA release form and ask them to read 
it. If the  respondent has questions, you should answer them. If they agree to participate, 
they need to sign 2 copies of each of these forms.  One copy of the consent form and HIPPA 
release form should be retained for their records; the other should be submitted to the 
health department.  
 
 
 
Continue with the survey on the following page.  
 
 
 Date  Time  
Start of survey administration    
Finish of survey administration    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  119 
 
SAY: To begin, I am going to ask you a series of basic questions about you currently. 
 
1. I know this may seem like an obvious question, but what race(s) do you consider yourself to be?  
[LET RESPONDENTS VOLUNTEER INFORMATION. CHECK ALL THAT APPLY] 
 
□ African American / Black / Negro [01]     □ Caucasian / White [02]     □ Asian Indian [03]      
□ American Indian or Alaska Native [04]     □ Japanese [05]     □ Chinese [06]     □ Korean 
[07]      
□ Native Hawaiian [08]     □ Filipino [09]     □ Other Pacific Islander [10]      
 
□ Some other race [11] 
______________________________________________________________  
 
□ Refused [999] 
 
2. What is your ancestry or ethnic origin? [LET RESPONDENTS VOLUNTEER INFORMATION.] 
 
FILL IN RESPONSE: 
____________________________________________________________________ 
 
□ Do not know [10] 
□ Refused [999] 
3a. Are you Spanish/Hispanic/Latino? [LET RESPONDENTS VOLUNTEER 
INFORMATION.] 
□ No, not Spanish/Hispanic/Latino [01]     □ Yes, Mexican, Mexican American, Chicano [02] 
□ Yes, Puerto Rican [03]    □ Yes, Cuban [04]      
□ Yes, other Spanish/Hispanic/Latino—Print group [05] 
____________________________________ 
      
 
□ Refused [999] 
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3b. Are you of Middle Eastern or North African descent?  
□ Yes  [01]     □ No  [02]      
 
 
□ Refused [999] 
4.  What gender do you consider yourself to be? [LET RESPONDENTS VOLUNTEER 
INFORMATION] 
 
□ Male  [01]     □ Female  [02]     □ Both male and female [03]    □ Neither male nor female 
[04]      
□ Other [05] _______________________________      
 
 
□ Refused [999] 
5.  Are you currently married, separated, divorced, widowed, living with a partner, or single? [LET 
RESPONDENTS VOLUNTEER INFORMATION] 
□ Married [01]  □ Separated [02] □ Divorced [03] □ Widowed [04]  
□ Living with a partner  [05] □ Single  [06]  
□ Other [07] _______________________________      
 
 
□ Refused [999] 
               
6. What is the highest grade or level of school you have completed or the highest degree you have 
received?  
□ Some high school [01]      □ High school or GED [02]     □ Some college [03]     
□ Bachelor or Associate’s Degree [04]      □ Advanced graduate degree [05]  
□ Other professional degree [06] 
 
□ Refused [999] 
 
SAY: For the next series of questions, I want you to think back to before you were diagnosed with TB. 
Answer the questions as you would have before you had TB. 
 
7. Before you had TB, would you say that your health was excellent, good, fair, or poor compared to other 
people your age? 
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□ Excellent [01]     □ Good [02]     □ Fair [03]     □ Poor [04]   
 
□ Refused [999]  
 
 
SAY: Now I am going to ask you about your personal behaviors before you were diagnosed with TB.  
 
8a. Did you ever drink beer, wine or liquor?  
□ Yes [01]  □ No [02]        
 
□ Refused [999]  
 
IF YES  CONTINUE TO #8B 
IF NO  CONTINUE TO #8D 
 
8b. In a typical month, about how many days did you drink beer, wine, or liquor?  
 
Days: _____________ 
 
8c. On days that you drank, about how many drinks did you have? By drink we mean a can or bottle of 
beer, glass of wine, shot of liquor, or a mixed drink.  
 
Drinks: ____________ 
 
IF RESPONDENTS ANSWERED #8B OR #8C, CONTINUE TO #9A. 
 
8d. Have you always abstained from drinking alcohol?  
□ Yes [01]  □ No [02]       □ Refused 
[999]  
 
9a. Did you smoke cigarettes before you had TB?  
□ Yes [01]  □ No [02]       □ Refused 
[999]  
 
IF YES  CONTINUE TO #9B.  
IF NO  CONTINUE TO #9C. 
 
9b. In an average day, how many cigarettes did you usually smoke?  
 
___________Cigarettes or ___________Packs  
 
IF RESPONDENT ANSWERS #9B, CONTINUE TO #10. 
 
9c. Have you ever smoked?  
□ Yes [01]  □ No [02]       □ Refused 
[999] 
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10. Before your diagnosis of TB, how often did you engage in active sports or exercise?  
 
□ Never [01] □ Less than once a week [02] □ Once a week [03]  □ Multiple times per 
week  [04] 
□ Almost every day  [05]   
 
□ Refused [999] 
 
 
SAY: Now I am going to ask you a series of questions about health care. Remember, you are still 
answering these like you would have before you were diagnosed with TB. 
 
11a. Suppose you had a health symptom that had been bugging you for a couple of weeks (something like 
a shooting pain in your back, persistent flu-like symptoms, headache that wouldn’t go away), how likely 
would you be to seek out medical attention?  
 
□ Very likely [01]     □ Somewhat likely [02]     □ Somewhat unlikely [03]     □ Unlikely [04]      
 □ Refused [999] 
 
11b. What are the biggest reasons you wouldn’t seek out medical attention? ([LET RESPONDENTS 
VOLUNTEER INFORMATION.ONLY READ ANSWER CHOICES IF RESPONDENT NEEDS 
PROMPTING)  
□ Cost [01] □ Too far away [02] □ Can’t take off work [03]  □ Lack of health 
insurance [04] 
□ Time/Inconvenience [05]  □ Fear of doctors or medical treatments [06]  □ Quality of 
care [07]  
□ Unpleasant interactions with healthcare professionals [08] □ No transportation [09]                                  
□ Embarrassed to see a doctor [10] 
□ Other (PLEASE SPECIFY) [11] ________________________   
 
□ Refused [999] 
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12. Now I’m going to list a series of locations in the community. On average, how often did you spend 
time in these locations before you were diagnosed with TB?  
 
Location  Daily [01] Weekly [02] Monthly 
[03] 
Never 
[06] 
Refused 
[999]  
a. Workplace: 
 
 
____________________ 
     
b. Place of worship  
(church, synagogue, 
mosque, temple)  
     
c. Schools (grade schools 
or universities) 
     
d. Corner 
stores/convenient stores  
     
e. Bar (club, nightclub, 
etc.) 
     
f. Liquor store       
g. Family member’s house       
h. Friend(s) or neighbor’s 
house  
     
i. Social or athletic clubs      
j. Homeless Shelter       
k. Jail or correctional 
facility   
     
l. On public transportation 
(bus, train) 
     
m. Long-term care, assisted 
living facilities, or group 
homes    
     
n. Healthcare facilities 
(doctors’ offices, clinics, 
hospitals) 
     
o. Other place (define): 
 
1) ____________ 
  
2) ____________ 
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SAY: For the remainder of the survey I want you to answer the questions currently—what I mean is 
that your responses to the questions should reflect your current status.  
 
The next questions are going to ask you about your residence and the area surrounding it.   
 
13. Do you have a permanent address? 
□ Yes [01] □ No [02]        □ 
Refused [999] 
 
IF YES  CONTINUE TO #14A 
IF NO  CONTINUE TO #14B 
14a. In the past 12 months are there times when you have been without a permanent address or homeless? 
□ Yes [01] □ No [02]        □ 
Refused [999] 
 
IF YES  CONTINUE TO #14B 
 IF NO  CONTINUE TO #15. 
 
14b. How many weeks in the past 12 months have you been without a permanent address or homeless? 
 
_________________________________weeks  
 
 
15. Altogether, how many people have you lived with in the past 12 months either temporarily or 
permanently (excluding yourself)?  
 
____________people  
 
16. Do you stay in the same place every night? 
□ All of the time [01]     □ Most of the time [02]     □ Some of the time [03]     □ Rarely [04]    
□ Never [05]                                      
□ Refused [999] 
 
17. Where do you stay most nights? (LET RESPONDENTS VOLUNTEER INFORMATION. DO NOT 
READ ANSWER CHOICES UNLESS NEEDED.) 
□ Their own home [01]     □ Intimate partner’s house [02]     □ Family member’s house [03]     
□ Shelter [04]      
□ Friend’s house [05]   □ On the street or in an abandoned building [06]         
□ Other [07] _______________________________      
 
 □ Refused [999] 
 
18. How many times have you moved in the last 12 months?  
□ 0 times  [01]     □ 1-2 times  [02]     □ 3-4 times  [03]     □ More than 5 times  [04]                  
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□ Refused [999] 
          
19. Do you live in public assistance or section 8 housing? 
□ Yes [01] □ No [02]        
 □ Refused [999] 
 
20. How would you rate the condition of where you live? 
□ Excellent [01]     □ Good [02]     □ Fair [03]     □ Poor [04]         
□ Refused [999] 
 
21. How would you rate the quality of your neighborhood, that is the area within 2-3 blocks of where you 
live? 
□ Excellent [01]     □ Good [02]     □ Fair [03]     □ Poor [04]        
 □ Refused [999] 
 
22. How would you rate the quality of your neighborhood compared to other neighborhoods in your city? 
□ Worse [01]     □ About the same [02]     □ Better [3]     
 □ Refused [999] 
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23. Next I am going to read you some statements about your neighborhood. For these statements, please 
indicate if you strongly agree, agree, are neutral, disagree, or strongly disagree with the statement. 
 
Statement Strongly 
agree 
Agree Neutral Disagree Strongly 
disagree 
a. I feel safe 
walking in my 
neighborhood, 
day or night. 
     
b. In my 
neighborhood 
the buildings 
and homes are 
well-
maintained.   
     
c. I live in a 
close-knit 
neighborhood.  
     
d. People in my 
neighborhood 
are willing to 
help each 
other.  
     
e. There are many 
vacant houses 
or deserted 
houses or 
storefronts in 
my 
neighborhood.  
     
f. Vandalism is a 
big problem in 
my 
neighborhood. 
     
 
SAY: For the next set of questions I am going to ask you to compare yourself to the people around you. 
Remember, you are answering these questions according to how you currently feel.  
 
NOTE TO THE INTERVIEWER: The following questions may be uncomfortable for participants 
to answer. Remind respondents they are welcome to skip any questions they are uncomfortable 
with.  
 
Thinking about your life, where would you place yourself among the following groups of people:  
 
24a. Your peers, by this I mean people that you spend time with that are around your age.  
 □ Below your peers [01]     □ Same as your peers  [02]     □ Above your peers [3] 
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 □ Refused [999] 
 
24b. Your neighbors or people in your community  
 □ Below your neighbors [01]     □ Same as your neighbors  [02]     □ Above your neighbors 
[3] 
   
□ Refused [999] 
 
24c. Other people in the U.S.  
 □ Below other people in the U.S. [01]     □ Same as other people in the U.S. [02]      
  □ Above other people in the U.S. [3]          □ Refused 
[999] 
   
 
SAY: The following questions ask about health insurance, your income and the kind of work you do. 
Please answer them according to your current status.  
 
Please indicate which, if any, of the following kinds of health insurance you have?  
 
25a. Medicare  
□ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
25b. Medicaid   
□ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
25c. VA or any other military health care plan 
□ Yes  [01]     □ No  [02]              
 □ Refused [999] 
 
25d. Health insurance through your employer (or spouse’s/partner’s employer) 
 □ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
25e. Another type of health insurance (FILL IN BELOW)  
 
______________________________________________________________________________ 
25f. No health insurance  
 □ Yes  [01]  □ No  [02]             
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 □ Refused [999] 
 
IF THERE IS ANY TYPE OF HEALTH INSURANCE, MOVE TO #27A.  
 IF THERE IS NO INDICATION OF ANY HEALTH INSURANCE, MOVE TO #26.  
 
26. What is the main reason that you do not have any health insurance right now?  [LET 
RESPONDENTS VOLUNTEER INFORMATION] 
 □ Cannot afford it/too expensive [01]            
 □ Just changed jobs [02] 
□ Do not want it [03]            □ Just moved [04] 
□ Do not need it [05]       □ Unemployed [06] 
□ My job doesn’t provide it [07]     □ I’m not full-time 
[08] 
□ Temporary visitor or refugee status [09]    □ Student without 
insurance [10] 
□ Insurance is outside of the U.S. [11]     □ I’m too ill to get it 
[12]  
□ Don’t know what to get [13] 
□ Other reason [14] 
__________________________________________________________________ 
 
□ Refused [999] 
 
       
 
 
 
27a. Now I’d like to ask you a few questions about the kind of work you do. First, are you working now 
for pay, looking for work, retired, a homemaker, a student, or something else? ([LET RESPONDENTS 
VOLUNTEER INFORMATION—CHECK ALL THAT APPLY) 
 
□ Working for pay [01]      □ Unemployed / Looking for work [02]     □ Retired [03]     
□ Homemaker [04]      □ Student [05] □ Not working  [06] 
□ Temporarily laid off, sick or maternity leave  [07]  
□ Unpaid family worker  [08] 
□ Other (Specify) [09] _________________________________________   
 
□ Refused [999] 
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     IF ANSWER # 2, 3  CONTINUE TO #27B. 
     ALL OTHER  CONTINUE TO #28.  
 
27b. When did you last work for pay? 
  
     [record month/year] __________________ 
 
28. How difficult is it for you to make your monthly bill payments?  
     □ Not difficult at all [01]     □ Somewhat difficult [02]     □ Very difficult [3]  
     □ Extremely difficult [4]     
   □ Refused [999] 
 
SAY: In order to get an accurate picture of your income, it helps to know the different sources of 
income you may have had in the past 12 months. We do not need detailed amounts, just whether you 
had income from the sources I will mention (this could be either you or your spouse/partner’s income).   
 
29a. Income from wages or salary  
□ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
29b. Unemployment compensations, disability or workers’ compensation    
□ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
29c. Social security payments, including payments for children 
□ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
29d. Retirement pay, such as pensions or 401 (K) accounts 
 □ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
29e. Public assistance payments such as food stamps or welfare  
 
□ Yes  [01]     □ No  [02]             
 □ Refused [999] 
 
 
29f. Any other sources of income (please list)  
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30. What is your total household yearly income from all sources (including your income from your job, 
government aid, and your spouse’s income)? Is it less than $15,000 per year, between $15,000—$30, 000 
per year, between $30,000—$75,000 per year, or is it more than $75,000 a year? 
 
□ < $15,0000 [01]      □ $15,000 – $30,000 [02]     □ $30,000 – $75,000 [03]     
□ > $75,000 [04]      □ Do not know [05] 
 
□ Refused [999] 
 
 
SAY: Now I am going to ask you a series of questions about your social life. Remember, you are 
answering them according to how you currently feel.  
 
People sometimes turn to others for companionship, assistance, or other types of support. How often 
are the following types of support available to you if need them?  
 
31. Someone to confide in or talk to about yourself or your problems.  
□ All of the time [01]     □ Most of the time [02]     □ Some of the time [03] 
□ None of the time [04]   □  Don’t Know/Not sure [05] 
 
□ Refused [999] 
 
32. Someone to take you to the doctor if you had to go.  
□ All of the time [01]     □ Most of the time [02]     □ Some of the time [03] 
□ None of the time [04]   □  Don’t Know/Not sure [05] 
 
□ Refused [999] 
 
33. Someone to help you with your daily chores if you were sick.  
□ All of the time [01]     □ Most of the time [02]     □ Some of the time [03] 
□ None of the time [04]   □  Don’t Know/Not sure [05] 
 
□ Refused [999] 
 
34. Someone to loan you $100 or less, if you needed it?  
□ All of the time [01]     □ Most of the time [02]     □ Some of the time [03] 
□ None of the time [04]   □  Don’t Know/Not sure [05] 
□ Refused [999] 
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SAY:  Lastly, I am going to ask you a couple of questions about your food status. Please answer them 
according to how you currently feel.  
 
35. How difficult is it for you to make your food last until you have money to buy more?  
    □ Not difficult at all [01]     □ Somewhat difficult [02]     □ Very difficult [3]  
      □ Extremely difficult [4]     
    □ Refused [999] 
 
36. How often are you able to eat fresh fruits and vegetables?  
      □ Everyday [01]     □ A few times per week [02]     □ Less than once per week [3]  
     □ Never [4]     
    □ Refused [999] 
 
37a. Have you had to cut down the number or size of your meals because of money? 
 □ Yes  [01]     □ No  [02]             □ 
Refused [999] 
 
IF ANSWER YES  CONTINUE TO #37B  
 
37b. How often have you had to do this? 
□ Everyday [01]     □ A few times per week [02]     □ Less than once per week [3]  
     □ Never [4]     
    □ Refused [999] 
 
 
SAY: That concludes the survey. Thank you very much for your time. (Hand participant the gift card) 
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THESE QUESTIONS ARE NOT GOING TO BE ASKED DURING THE SURVEY BUT SHOULD 
BE EXTRACTED FROM THE PATIENT CHART.  
 
 
Information to be extracted from RVCT form  
1.County of residence   
2. Age (in years)   
 
3. Primary Reason 
Evaluated for TB  
□ TB symptoms [ 01 ]         □ Abnormal chest radiograph [ 02 ]   
□ Contact investigation  [ 03 ]     □ Immigration medical exam  
[ 04 ]  
□ Targeted testing [ 05 ]   □ Health care worker  [ 06 ] 
□ Employment/administrative testing  [ 07 ]  □ Incidental lab 
report  [ 08 ] 
□ Other  [ 09 ] 
  
4. Site of TB disease □ Pulmonary  [ 01 ]  □ Extra-pulmonary  [ 02 ]□ Unknown  [ 
03 ] 
 
5. Symptoms at time of 
diagnosis 
□ Chronic cough [ 01 ]         □ Weight loss [ 02 ]   
□ Night sweats  [ 03 ]     
 □ Other (please specify below)  [ 04 ]  
 
 
 
 
6. HIV Status  □ Negative  [ 01 ]    □ Positive  [ 02 ]    □ Indeterminate  [ 03 ]   
□ Refused  [ 04 ]  □ Not offered  [ 05 ]  □ Test done, results 
unknown  [ 06 ] 
□ Unknown  [ 07 ] 
7. Country of Origin □ U.S. born [ 01 ]  □ Foreign Born  [ 02 ] 
8. Immigration Status □ Not applicable/U.S.-born  [ 01 ]  □ Immigrant Visa  [ 02 ] 
□ Asylee/parolee/refugee  [ 03 ] 
□ Student Visa  [ 04 ]      □ Tourist Visa  [ 05 ] 
□ Other Immigration Status  [ 06 ] 
  133 
□ Unknown  [ 07 ] 
 
9. Homeless within past 
year  
□ No  [ 01 ]  □ Yes  [ 02 ] 
□ Unknown  [ 03 ] 
  
10. Resident of 
correctional facility at time 
of diagnosis 
□ No  [ 01 ]  □ Yes  [ 02 ] 
□ Unknown  [ 03 ] 
 
Previous Medical 
Diagnoses 
Currently  Before TB 
diagnosis 
No Unknown 
11a.High blood sugar or 
diabetes 
    
11b. Chronic lung 
condition (i.e. bronchitis, 
emphysema, or COPD 
    
11c. Asthma     
11d. High blood pressure 
or hypertension  
    
11e. Cancer     
11f. Arthritis      
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